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Nitric Oxide (•NO) is an essential biomolecule that has physiological functions in 
neurotransmission, vasodilation and immune response. •NO is produced by a family of enzymes 
known as nitric oxide synthases (NOS). NOS catalyze the conversion of L-arginine into L-citrulline 
and •NO. Due to their physiological relevance, abnormal •NO production by NOS has been linked to 
several disease states. There are three isoforms found in mammalian cells: neuronal (nNOS), 
endothelial (eNOS), and inducible (iNOS), each involved in different physiological processes. Both 
nNOS and eNOS are constitutively expressed and are therefore referred to as cNOS enzymes. In 
contrast, iNOS is transcriptionally regulated by cytokines in macrophages. NOS are homodimeric 
proteins comprised of an N-terminal heme-oxygenase domain and a C-terminal flavin-binding 
reductase domain, linked together via a calmodulin (CaM) binding domain. Lastly, NOS activity is 
regulated by a small ubiquitous Ca2+-binding protein known as Calmodulin (CaM). Interestingly, 
cNOS isozymes are Ca2+-dependent in terms of CaM binding, whereas iNOS is Ca2+-independent. 
The exact mechanism of CaM’s control over •NO production is not yet fully understood. 
Evidence suggests that CaM triggers a large conformational change in NOS to occur that allow for 
efficient electron transfer. In addition, past studies have investigated how varying different structures 
and elements within CaM affect NOS catalytic activity through the use of CaM mutants in NOS 
activity assays. These assay methods have shown to be expensive, lengthy and labour intensive. There 
is a need for a more facile and robust method to evaluate NOS-CaM interactions.  
In this investigation, the NOS-CaM interaction was further characterized by observing the 
binding kinetics of previously studied CaM mutant proteins binding to peptides that corresponded to 
the CaM-binding domain of all three NOS isoforms through the use of a spectroscopic technique 
known as surface plasmon resonance (SPR). SPR is an optical phenomenon that measures and 
quantifies the adsorption of compounds onto conducting metal surfaces. This SPR study was used to 
correlate the binding kinetics of mutant CaM proteins with previous enzyme kinetic investigations.  
In addition, we attempted to improve current methods to measure NOS activity through the 
creation of a NOS electrochemical biosensor. Electrochemical biosensors utilize the catalytic 
activities of redox enzymes immobilized onto electrode surfaces where the biological activities of 
these enzymes are converted into measurable electrical signals. However, there is evidence of current 
electrochemical platforms that show denaturation of these redox enzymes when directly immobilized 
 
 iv 
on electrode surfaces. As a way to circumvent the known denaturation of these electrode immobilized 
enzymes, we used a modified CaM protein tether to indirectly immobilize NOS enzymes. We used 
the SPR platform as a preliminary immobilization test for NOS, but overall, we were not able to 
achieve specific binding. The development of a viable NOS electrochemical biosensor would allow 
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1.1 Nitric Oxide in Biological Organisms  
The works of R. Furchgott, L. Ignarro and F. Murad in the 1980’s led to the discovery, identification and 
characterization of nitric oxide (•NO) as an important signalling molecule. •NO is a gaseous, highly 
reactive, free-radical species that is an essential biological regulator involved in a plethora of 
physiological processes: neurotransmission, vasodilation and immune response (Alderton et al., 2001). 
•NO’s functions in neurons range from synaptogenesis, sensory input processing, synaptic plasticity and 
learning, and most importantly as a nonadregernic-noncholinergenic (NANC) neurotransmitter (Meffert 
et al., 1994; Schmidt & Walter, 1994). Additionally, •NO can activate soluble guanylyl cyclase in smooth 
muscle cells that surround blood vessels. This increases cellular cyclic guanosine monophosphate 
(cGMP), a secondary messenger that activates the lowering of intracellular calcium (Ca2+) levels, 
resulting in the vasodilation of blood vessels (Schmidt et al., 1993; Schmidt & Walter, 1994). Lastly, as a 
reactive nitrogen species (RNS), it can be used as a cytotoxic agent as a means for immunological defense 
through cell-mediated immune response against microbes, tumour cells and alloantigens (Kroncke et al., 
1998; Nathan & Hibbs, 1991). 
 
1.2 Nitric Oxide Synthase  
The production of •NO in tightly regulated by a family of enzymes knows as nitric oxide synthases (NOS; 
EC 1.14.13.39). NOS catalyze the mono-oxygenation reaction of L-arginine (L-Arg) to an intermediate, 
N-ω-hydroxy-L-arginine (L-NOHA), with a subsequent second mono-oxygenation reaction converting L-
NOHA into L-citrulline and •NO (Figure 1.1). Each step of this reaction consumes a nicotinamide 





Figure 1.1 - The enzyme catalyzed reaction of L-arginine conversion into L-citrulline and •NO by 
NOS  
NADPH provides reducing equivalents for the conversion of L-arginine to L-citrulline and •NO by NOS 
catalysis. This figure is adapted from a previous review (Daff, 2010), using ChemBioDraw.  
 
Three different isoforms of NOS have been identified in mammalian tissues: neuronal NOS 
(nNOS; NOS1), endothelial NOS (eNOS; NOS III) and inducible NOS (iNOS; NOS II) (Alderton et al., 
2001). nNOS, eNOS and iNOS were each primarily found to be expressed in nervous tissues, epithelium 
tissues and macrophages, respectively, but are now known to be expressed in several different tissues 
throughout the body (Bachetti et al., 2004; Kroncke et al., 1998). All three isozymes are catalytically 
active only when in their dimeric form and bound to a small protein known as calmodulin (CaM), in a 1:1 
ratio (Alderton et al., 2001; Daff, 2010).  
 
1.2.1 Importance of Studying Nitric Oxide Synthase  
The production of •NO is important for maintaining normal physiological conditions. However, the 
aberrant production of this diatomic molecule has been linked to several pathological conditions. The 
uncoupling of the NOS enzymatic reaction (Figure 1.1) can produce superoxide (O2
-) instead of •NO. O2
- 
can react in turn with any surrounding •NO to generate more reactive nitrogen species (RNS), such as 
peroxynitrite (ONOO-). These RNS and other reactive oxygen species (ROS) can cause oxidative damage 
to surrounding biomolecules (Roe & Ren, 2012; Schmidt & Walter, 1994). Overproduction of •NO due to 
increased iNOS activity has been associated with immune response-related and inflammatory diseases 
such as immune-type diabetes, arthritis and Crohn’s disease (Kroncke et al., 1998; Schmidt & Walter, 
1994). Overproduction of •NO due to increased nNOS activity has been associated with 
neurodegenerative disorders such as Parkinson’s and Alzheimer’s disease (Xue et al., 2010; Zhang et al., 
2006). In contrast, •NO produced by eNOS mainly plays a physiological role and is important for blood 
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pressure regulation. Thus, the underproduction of •NO due to the lack of eNOS activity has been 
associated with cardiovascular diseases such as hypertension and atherosclerosis (Förstermann & Münzel, 
2006; Roe & Ren, 2012).   
Developing isoform-selective inhibitors for nNOS and iNOS isozymes over eNOS is of great 
interest due to the pathological diseases arising from •NO overproduction mentioned above. Nonetheless, 
finding isoform-selective inhibitors has proven to be difficult for several reasons. Firstly, the high 
conservation of the L-arg substrate binding pocket within the oxygenase dimer between all three isozymes 
make isoform selectivity a challenge for structure-based design (Alderton et al., 2001; Xue et al., 2010).  
Secondly, inhibitor studies are usually done using non-mammalian NOS isoforms such as rat nNOS and 
murine iNOS. Rat nNOS is the most thoroughly investigated nNOS isoform due to its 90% sequence 
homology to human nNOS and its reliable expression and purification. However, the slight difference in 
sequences has caused discrepancies in inhibitor sensitivity between human and non-human isoforms. This 
makes pharmacokinetic and pharmacodynamic studies hard to analyze and compare inhibitor efficacies 
(Fang et al., 2009; Joubert & Malan, 2011; Xue et al., 2010). Lastly, current in vitro inhibitor-enzyme 
assays for NOS are limited in that they are lengthy and use expensive regents. With these factors in mind, 
there is a need for a convenient, high-throughput analysis method to study NOS enzymatic activity.    
 
1.2.2 Nitric Oxide Synthase Expression  
Both nNOS and eNOS isozymes are constitutively expressed and are referred to as constitutive NOS 
(cNOS) isoforms. These isoforms are activated by elevated intracellular Ca2+ concentrations through the 
binding of CaM and are thus classified as Ca2+-dependent (Ghosh, Dipak, 2003). Unlike the cNOS 
enzymes, iNOS is transcriptionally regulated by endotoxins and cytokines in macrophages, although, 
there are reports of specific epithelial cell types that can constitutively express iNOS (Geller & Billiar, 
1998; Guo et al., 1995). iNOS binds CaM tightly regardless of the Ca2+ concentration, and is thus referred 
to as Ca2+-independent. The dependence of iNOS viability to CaM binding is so high it is usually 
expressed and purified in the CaM-bound state (Geller & Billiar, 1998; Stevens-Truss & Marletta, 1995).  
 
1.2.3 Nitric Oxide Synthase Structure 
The nNOS, eNOS and iNOS isozymes share approximately 50-60% sequence homology in humans and 
have molecular weights of 165kDa, 134kDa and 130kDa, respectively. All three enzymes are 
homodimeric, where each monomer is composed of 2 main domains: an N-terminal oxygenase domain 
and a multi-subdomain C-terminal reductase domain (Figure 1.2). The 2 domains are linked together via a 
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CaM-binding site domain (Figure 1.2; Section 1.3.1)  (Alderton et al., 2001; Daff, 2010). There are 
currently no full-length crystal structures of any NOS enzymes, however several individual domains have 
been characterized and reported (Fischmann et al., 1999; Garcin et al., 2004; Li et al., 2001; Matter et al., 
2005). 
 
Figure 1.2 - Monomeric nNOS, eNOS & iNOS Domain Structure 
The oxygenase and reductase domain are shown in red and pink respectively. The numbers represent the 
amino acid residues at the start and end of each respective NOS’s oxygenase domain, and the reductase 
FMN and FAD/NADPH subdomains. Figure reprinted with permission from (Alderton et al., 2001).  
 
1.2.3.1 Nitric Oxide Synthase Oxygenase Domain  
The oxygenase domain contains the catalytic site and has binding sites for the substrate, L-arg, molecular 
oxygen (O2), iron protoporphyrin (heme) and the cofactor (6R)-5,6,7,8-tetrahydrobiopterin (H4B). The 
heme domain in NOS can be compared to those in cytochrome P450 (P450; EC 1.14.-.-) enzymes, in that 
both catalyze the oxidations of substrate molecules bound close, but not directly ligated, to a penta-
coordinated thiolate ligated heme iron. The heme groups between each enzyme however have 
fundamental structural and functional differences (Alderton et al., 2001; Daff, 2010). All of these binding 
sites are highly conserved between NOS isoforms, although nNOS has a unique binding domain called 
the post synaptic density protein 95 (PSD-95) discs large/ZO-1 homology (PDZ) domain (Figure 1.2). 
The PDZ domain is located in the 220 amino acid N-terminal extension of nNOS, attributing to the larger 
size of this enzyme compared to the other isoforms. The PDZ domain is used for the localization and 
targeting of nNOS to specific areas in the cell (Brenman et al., 1996; Zhou & Zhu, 2009). Several crystal 
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structures of the oxygenase domain of all NOS isoforms have been published (Figure 1.4) (Fischmann et 
al., 1999; Li et al., 2001; Matter et al., 2005). They show that the dimer interface of NOS occurs between 
the two oxygenase domains and contain a structural zinc ion tetra-coordinated to 2 conserved cysteine 
residues from each monomer (Li et al., 2001; Raman et al., 1998). 
 
1.2.3.2 Nitric Oxide Synthase Reductase Domain  
The reductase domain is comprised of the flavin adenine dinucleotide/nicotinamide adenine dinucleotide 
phosphate (FAD/NADPH) and the flavin mononucleotide (FMN) subdomains and each has binding sites 
for the respective cofactors (Alderton et al., 2001).  Notably, the FAD/NADPH subdomain has structural 
and functional homology to cytochrome p450 oxidoreductases (CYPOR; EC 1.6.2.4.) but not the FMN 
subdomain (J. Zhang et al., 2001). Currently, solved structural data on the reductase domain is limited to 
only the nNOS isoform (Figure 1.3) (Garcin et al., 2004).  
 
Figure 1.3 - Structures of NOS Oxygenase Domains & NOS Reductase Domain 
(A) rat nNOS oxygenase domain (B) human eNOS oxygenase domain (C) human iNOS oxygenase 
domain (D) rat nNOS reductase domain. All solved structures depict domain dimers. NOS oxygenase 
monomers are shown in blue and sky blue. nNOS reductase monomers are shown in red and pink. H4B, 
heme, L-Arg, FAD, FMN, Fe, & Zn2+ are shown in light green, red, yellow, purple and turquoise sticks 
and orange and magenta balls respectively. Models were derived from PDB 1ZVL, 3NOS, 4NOS and 
1TLL respectively (Fischmann et al., 1999; Garcin et al., 2004; Li et al., 2001; Matter et al., 2005), and 




CaM is a ubiquitous cytosolic calcium (Ca2+)-binding protein that can be found in all eukaryotic 
organisms. It is involved in the regulation of many different proteins, one of them being NOS. CaM is 
known to acts as a signal transducer for a wide variety of physiological processes (Babu et al., 1988). 
CaM is a relatively small protein with a length of 148-amino acids (16.7 kDa) and it is made up of 
globular N- and C-terminal domains tethered by a central flexible linker region (Figure 1.4). CaM has 
been reported to bind to approximately 300 target proteins (Ikura & Ames, 2006). This protein can chelate 
up to a total of 4 Ca2+ ions through 2 pairs of EF-hand motifs, found in each terminal domain. Ca2+ binds 
cooperatively within each domain, where the C-terminal lobe has approximately 10-fold greater affinity 
for Ca2+ than the N-terminal lobe (Bayley et al., 1996).  Although CaM can exist in various Ca2+ bound 
states, it is primarily found in two states: the Ca2+-free state (apo-CaM) and the Ca2+-saturated state (holo-
CaM).  
 
Figure 1.4 - Calmodulin in various Ca2+-bound states 
(A) Apo-CaM (Kuboniwa et al., 1995) (B) Holo-CaM (Chattopadhyaya et al., 1992) (C) Holo-CaM in 
compact form (Fallon & Quiocho, 2003). The N-terminal, C-terminal and linker region are colored in 
cyan, blue and grey, respectively. Ca2+ ion are colored in yellow. Models were derived form PDB 1CFD, 
1CLL, 1PRW, respectively and viewed using UCSF Chimera.  
Apo-CaM has a relatively compact conformation, whereas holo-CaM appears to be more dynamic 
and can range from an extended state (dumbbell-shaped) to a compact state, with various intermediate 
conformations in between (Figure 1.4) (Finn & Forsén, 1995). This flexibility can be attributed to the 
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central linker region, which can be readily bent and unravelled, allowing the N- and C-terminal domains 
to change orientation, giving CaM the ability to bind several different target proteins (Chou et al., 2001). 
Additionally, the amino acid composition of these domains contains a significant amount of hydrophobic 
and acidic residues. The C-terminal domain has slightly higher hydrophobic and acidic character, giving 
CaM the ability to accommodate a wider variety of amino acids in the target peptide (Ikura & Ames, 
2006). 
 
1.3.1 The Nitric Oxide Synthase Calmodulin-Binding Domain 
As mentioned previously, CaM can bind target proteins in a Ca2+-dependent and -independent manner, in 
the holo and apo forms respectively. It recognizes peptide sequences that are approximately 20 amino 
acids long and can form basic, amphipathic α-helical secondary structure. Although sequences between 
target proteins can vastly differ in sequence identity, positions of bulky hydrophobic amino acids are 
highly conserved (Yap et al., 2000). CaM can bind in a Ca2+-dependent manner to the CaM-binding 
domains of target proteins that contain a recognition motif in the form 1-5-8-14, 1-8-14 or 1-5-10, where 
the amino acids at these positions are either F-A-I-L-V or W, with some exceptions (Figure 1.5). CaM can 
also bind in a Ca2+-independent manner to target proteins that have the IQ motif, a consensus sequence of 
IQ-XXX-RG-XXX-R, where X can be any amino acid. However, the IQ motif can be found in some 
Ca2+-dependent proteins (Rhoads & Friedberg, 1997).  
The CaM-binding domain of all NOS isozymes all share the 1-5-8-14 CaM binding motif, where 
the residue at position 1 is usually an aromatic amino acid, 5 & 8 are hydrophobic, and 14 is bulky and 
hydrophobic (Figure 1.5) (Aoyagi, 2003; Venema et al., 1996).  
        1          5      8              14 
Human  nNOS RRA I G FKKLAEAVKFSA KLMGQAMAKRV  (731-758) 
Human eNOS TRK KT FKEVANAVKI SA S LMGTVMAKRV  (491-518) 
Human iNOS RRE I  P LKVLVKAVLFACMLMRKTMAS RV  (510-537) 
Figure 1.5 - Sequence alignment of the human NOS CaM-binding region 
Alignment was taken from a previous study (Aoyagi, 2003). Basic residues are shown in blue and acidic 
residues in red.  
Structural studies of CaM binding to peptides of the NOS CaM-binding domain reveal that CaM 
wraps tightly around the peptides in an antiparallel orientation, where the N-terminal residues of CaM 




1.4 Nitric Oxide Synthase Electron Transfer  
During NOS catalysis, it is generally understood that upon initiation of CaM binding to the CaM-binding 
domain, electrons are shuttled from the reductase domain of one monomer of the quaternary structure to 
the heme oxygenase domain of the opposite monomer (Volkmann et al., 2014). However, the exact 
mechanism of the electron transport within NOS is still under investigation. Research using electron 
microscopy (EM) has demonstrated that NOS adopts several different structural conformations during 
electron transport (Campbell et al., 2014; Leferink et al., 2014). The binding of NADPH in the 
FAD/NADPH subdomain reduces FAD by two electrons. Through interaction with the FMN subdomain, 
which is buried within the reductase domain, FAD donates one electron to FMN, but the FMN remains 
inaccessible to the heme in the oxygenase domain. This is known as the “input” or “closed state” (Figure 
1.6). A significantly large conformational change occurs that releases the FMN subdomain from the 
reductase domain closer towards the oxygenase domain where FMN can donate the electron to the heme 
cofactor. This is known as the “output” or “open state” (Figure 1.6) (Campbell et al., 2014; Ghosh & 
Salerno, 2003; Roman & Masters, 2006; Smith et al., 2013; Volkmann et al., 2014).  
 
Figure 1.6 - Electron transport in NOS 
Individual monomers are depicted in light and dark blue. (A) depicts the input state showing the 
interaction between the FAD/NADPH and FMN subdomains (electron transport between 
NADPHFADFMN). (B) depicts the output state showing the interaction of the FMN subdomain with 
the opposite heme oxygenase domain (electron transport between FMNheme). This figure was 
reprinted and adapted with permission from Proc. Natl. Acad. Sci. (PNAS) U. S. A, 111 (35) (Campbell 
et al., 2014).  
 
1.4.1 Calmodulin’s Role In Activation of Nitric Oxide Synthase Electron Transport 
Due to the lack of structural data of the full NOS holoenzymes, the exact mechanism and role of CaM 
activation of NOS for •NO catalysis is not yet fully understood and is still being elucidated. Several 
different models have been proposed but there is yet to be a consensus as to which model is correct. 
Interestingly, the EM research mentioned in in Section 1.4 suggest an actual multi-step mechanism for the 




Campbell et al. (2014) propose that upon CaM binding, the input state is destabilized and releases 
the FMN subdomain from its interaction with the FAD/NADPH subdomain (Figure 1.7). This mechanism 
accounts for the large conformational change in NOS that minimizes the distance between the FMN 
subdomain to the heme oxygenase domain for electron transport. Due to the tight binding of CaM by 
iNOS at basal levels, this mechanism is unique to the cNOS isoforms (Campbell et al., 2014; Nishida & 
de Montellano, 1998; Smith et al., 2013). The second step proposes that CaM stabilizes the interaction 
between the FMN subdomain to the heme oxygenase domain by binding directly to the oxygenase dimer 
interface, forming a calmodulin-docked intermediate (Figure 1.7). This constricts the rotational movement 
of the FMN subdomain, locking it into the output state, causing the rapid and efficient transfer of 
electrons (Campbell et al., 2014; Smith et al., 2013).  
 
Figure 1.7 - Proposed conformational changes during NOS electron transport 
Individual NOS monomers are depicted in light and dark blue, and CaM in light green. Yellow arrows 
suggest direction of electron transfer. Dashed grey arrows on the ends suggest both of the reductase 
domain are highly flexible with respect to the oxygenase domain, adopting a range of conformations 
when the enzyme is in a resting state. Grey arrows suggest the conformational changes instigated upon 
CaM binding, where the FMN subdomain is pulled away from the NADPH/FAD subdomain (input state). 
Another conformational change occurs where CaM is able to bind to the oxygenase dimer (calmodulin-
docked intermediate), promoting a second FMN transition that brings it closer to the oxygenase domain 
of the opposite monomer, allowing for efficient electron transfer (output state). Only one FMN domain 
participates in electron transfer at a time, where the opposite reductase domain remains in the input state, 
unaffected by the large conformational changes occurring in the opposite monomer. This figure was 




1.5 Reasons for Studying the Nitric Oxide Synthase – CaM Interaction 
Understanding the molecular mechanisms and interactions that govern the processes and reactions of 
enzymes within biological organisms is of major interest in many fields of science, with importance in 
areas of molecular biology, biochemistry, medicine and proteomics. To achieve this goal, it is essential to 
identify and characterize how they interact with their regulating protein partners to fully understand their 
roles and functions.  
More specifically, over the last few decades, there has been much interest in fully understanding 
the dynamic interplay between NOS enzymes and their regulation by CaM proteins. There are two main 
questions about this protein-protein interaction that are currently under investigation: 
(1) How does CaM bind NOS enzymes, and; 
(2) How does CaM activate NOS enzymes 
Interestingly, there are two emerging techniques that could be used to study the NOS-CaM interaction. 
These techniques include surface plasmon resonance and bioelectrochemistry.  
 
1.5.1 Surface Plasmon Resonance  
Surface plasmon resonance (SPR) spectroscopy is an analytical technique that can be used to monitor the 
adsorption of compounds onto diaelectric metal surfaces such as gold. With vast advances in the past 
decade for the development of SPR technology and its applications, SPR biosensors have become a 
central tool for characterizing and quantifying bimolecular interactions.  
 
1.5.1.1 Surface Plasmon Resonance Theory 
The surface plasmon polariton, also known as propagating plasmons, is an electromagnetic wave that runs 
parallel to the metal surface and is sensitive to changes in the surface composition (Homola et al., 1999). 
A beam of plane-polarized light is directed onto the surface and reflected back into a detector (Figure 
1.8). Upon stimulation of polarized light onto the surface, energy is absorbed by free electrons in the 
metal layer causing a resonant oscillation and thus, the phenomenon known as SPR (Piliarik et al., 2009). 
The absorption of energy causes a decrease in the intensity and the detector can measure the change in the 
angle of intensity decrease (Figure 1.8). Any change onto the surface due to binding will affect the 
surface plasmon, shifting the resonance angle, which is linearly proportional to the mass of the bound 
material (Homola et al., 1999). With this is mind, advances in SPR technology have gained popularity in 
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the past few years for becoming a widely used tool for its ability in biological and chemical sensing 
(Pattnaik, 2005). 
 
Figure 1.8 - Principles of SPR Detection 
A cartoon depiction highlighting that principles of SPR sensor optical detection. This figure was reprinted 
from (Hegyi et al., 2013) [Open Source].  
 
1.5.1.2 Surface Plasmon Resonance Kinetic Analysis  
A typical SPR kinetic analysis consists of 3 phases: the immobilization phase, the association/dissociation 
phase, and lastly, the regeneration phase. During immobilization, the ligand is usually bound to the 
surface of the chip using the gold-thiol covalent link, which is very stable and usually does not require the 
modification of the ligand other than the addition of a thiol group. The ligand must contain some reactive 
groups (such as –NH2, –SH, –COOH). Most often, thiol and amino groups are used for immobilization; 
however, the streptavidin-biotin linkage is also popular when studying protein complexes (Homola et al., 
1999).  
The next phase consists of the association and dissociation phase in conjunction with the 
regeneration phase (Figure 1.9). A predetermined concentration of analyte in running buffer can be 
titrated into the flow channel, thus interacting and binding with the immobilized ligand, causing a change 
in the resonance angle that is displayed as a Resonance Unit (RU) (Figure 1.9; association phase) (Piliarik 
et al., 2009). A steady state is reached when the amount of analyte molecules binding is equal to the 
amount of analyte bonds breaking, where this response corresponds to the concentration of the bound 
sample (Figure 1.9). Subsequently, the system is allowed to flow with running buffer in the absence of 
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analyte, removing any weakly associated analyte molecules (Figure 1.9; dissociation phase). Over time, 
the analyte–ligand complex will eventually dissociate, although very slow. Therefore, a regeneration 
solution is injected, usually containing harsh conditions, such as low pH, high salt concentration or a 
solution that has been predetermined to break apart the interaction, to instantly break apart the analyte-
ligand complex (Figure 1.8; regeneration phase;). This cycle of association/dissociation and regeneration 
can be repeated several times with varying concentrations of analyte to get a robust data set that can be 
analyzed for binding kinetics (Piliarik et al., 2009).  
 
Figure 1.9 - SPR kinetic analysis 
A typical response curve, also known as a sensogram, observed for a real-time SPR analysis of ligand-
analyte bimolecular interactions. This figure was reprinted from (Kardos, 2013) [Open Source]. 
The last phase concludes with post-analysis of SPR data. The sensograms can be analyzed using 
tracing software that fit the data according to pre-determined mathematical binding models. The fitting 
model outputs the rate constants for association and dissociation, ka & kd, along with the binding affinity 
constant, KD (Zoche, Bienert, et al., 1996).  
 
1.5.1.3 Surface Plasmon Resonance Advantages and Disadvantages 
A big advantage of using SPR is that the binding kinetics can be followed in real-time on the sensogram. 
Furthermore, the analyte of interest does not require modification or labelling keeping their properties 
unchanged, which is important in trying to understand in vivo interactions (Homola et al., 1999). The chip 
can be regenerated with the bound ligand and can be reused several times, allowing for measurements of 
different binding partners. In addition, a turbid analyte sample does not affect the measurement as the 
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interaction of the ligand and analyte should have been pre-selected for specificity. Lastly, SPR systems 
are quite sensitive and have low detection limits, often times in the nanomolar range, therefore low 
amounts of material can be used (Piliarik et al., 2009). 
On the other hand, SPR is severely limited in that the immobilization of the ligand could interfere 
with the binding reaction by orienting the binding region toward the chip surface or if the immobilization 
occurs through the same groups as those involved in ligand interactions (O’Shannessy & Winzor, 1996). 
However, this problem can be avoided through the use of linkers or functionalized surfaces. Another main 
disadvantage is that binding interactions occur on a surface and not in solution phase, thus interactions 
might differ from those observed under in vivo conditions (Karlsson & Fält, 1997). Furthermore, artificial 
increased binding affinity can occur due to increased localized concentration. In the case of multiple 
binding sites, the interpretation of results could become complicated (Nieba et al., 1997; O’Shannessy & 
Winzor, 1996). Molecules of molecular weight that are <300-500 Da might be too small for a quantitative 
measurement. And lastly, the binding orientation of the immobilized ligand is not well-defined as it 
cannot be observed (Homola et al., 1999; O’Shannessy & Winzor, 1996).  
 
1.5.2 Bioelectrochemistry 
The study of any enzyme protein, such as NOS, usually requires the measurement of its ability to carry 
out its enzymatic reaction. Due to the physiological relevance of NOS activity (Section 1.2.2.), it is 
crucial to understand how this enzyme is regulated. Fully comprehending the protein-protein interactions 
that govern this particular enzymatic process could give us more control in clinical design, such as 
developing new isoform-selective inhibitors that could be used to treat pathological disease states arising 
from irregularities in NOS expression (Section 1.2.2).   
Current methods to measure NOS activity are kinetic and end-point determination assays, which 
measure the enzymatic rate of product formation from a substrate and quantify the total amount of 
product formed. Some specific examples of assay methods that monitor NOS activity are the hemoglobin 
(Hb) assay and the NADPH assay. Both assays are labor intensive methods that require frequent time-
point measurements (Kelm et al., 1997). Additionally, they extensively require expensive reagents such as 
NADPH. Although these methods are sensitive and accurate, the time requirement, amount of work and 
monetary costs are great limiting factors when one needs to analyze several samples (Kelm et al., 1997) . 
Therefore, the development of an efficient, high throughput method that can measure NOS enzymatic 
activity is of great importance.  
 
 14 
As a developing field in science, bioelectrochemistry attempts to use electro and biophysical 
chemistry concepts to better understand and manipulate biological systems. A popular application of this 
area of research is direct electrochemistry of redox enzymes and the development of new biosensors 
(Armstrong et al., 1988). Intriguingly, in these studies, electrode surfaces provide a stable source of 
electrons for the enzymatic activity of immobilized redox proteins, thus eliminating the need for 
expensive and limiting substrates such as NADPH (Schneider & Clark, 2013). These new biosensing 
platforms have proven to be fast, relatively easy to complete and are also highly repeatable (Schneider & 
Clark, 2013), showing some potential for the development of a brand new platform to study NOS activity.  
 
1.6 Research Objectives 
The purpose of this Masters study is to further improve our understanding of CaM’s control over NOS 
function by investigating how different structural and regulatory elements of CaM affect its binding to 
NOS enzymes and correlate how those elements affect NOS enzymatic activity.  
Furthermore, we are trying to improve current methods to measure NOS activity by developing a 
brand new electrochemical NOS biosensor that will make the clinical design and screening of new 
isoform-selective inhibitors easier to accomplish.  
  These goals will be achieved by:  
(1) Investigating the binding kinetics of various CaM mutants binding to immobilized peptides that 
represent the canonical CaM-binding domain of NOS enzymes through the use of SPR 
spectroscopic methods.  
(2) Correlating the binding kinetics with the NOS activity profiles determined by activation of the 
same CaM mutants & elucidate the relationship between mutant CaM binding and activation. 
(3) Using the principles of bioelectrochemistry, we plan to directly immobilize NOS enzymes onto a 
gold electrode surface, eliminating the need for expensive reducing equivalents for the 
development of a robust and efficient NOS biosensor. We will circumvent the known denaturing 
effect of electrode fouling of proteins through the use of a CaM protein tether. We will first use 
optical SPR methods to test the immobilization of our CaM tether construct onto a gold surface, 
and observe if we can specifically bind NOS enzymes before the use of an electrochemical 
platform.    
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Chapter 2  
A Localized Surface Plasmon Resonance Study on Mutant CaM 
Binding with NOS Target Peptides 
 
2.1 Introduction 
There have been numerous experiments done in previous years that have looked at the dynamic 
interplay between CaM and NOS enzymes. A range of biophysical methods have been utilized in attempts 
to understand CaM’s control over •NO production by characterizing CaM binding and activation of NOS 
enzymes. Characterization of this protein-protein interaction has been done by analyzing the structure 
with methods such as cryo-electron microscopy (cryo-EM), x-ray diffraction (XRD) and nuclear magnetic 
resonance (NMR) (Alderton et al., 2001; Campbell et al., 2014; Piazza et al., 2012), as well as analyzing 
the binding kinetics with methods such as affinity chromatography, gel filtration and isothermal titration 
calorimetry (ITC) (Piazza et al., 2017; Spratt et al., 2006) 
Other binding experiments that have also been completed used methods such as SPR, competition 
assays, and fluorescence resonance energy transfer (FRET) and stopped-flow spectroscopy to determine 
rate constants for the binding of CaM proteins to target peptides that represent the CaM-binding domains 
of each of the NOS enzymes (Table 2.1). The differences in values for the binding rate parameters seen in 
Table 2.1 can be attributed to the differences in the techniques used. Despite these differences, these 
studies have showed a general trend in which CaM binding to cNOS peptides is Ca2+ dependent with 
respect to cNOS enzymes at all concentrations, whereas CaM binding to the iNOS peptide is Ca2+ 
independent, relatively irreversible and has a higher affinity compared to the cNOS peptides. 
Furthermore, the order of CaM affinity for the associated peptides can be noted as iNOS>>eNOS>nNOS. 
Overall, CaM is essential for NOS activity, and by understanding how it binds, we can understand more 





Table 2-1 - CaM binding kinetics of NOS peptides 
 
NOS Peptide ka (M
-1s-1) kd (s
-1) KD (nM) 
nNOS 1.58 x 105 (a) 
6.6 x 108 (b) 




iNOS 3 x 104 (a) 
--- 
6.1 x 108 (b) 
< 10-6 (a) 
--- 
0.063 (b) 









(a) SPR studies of CaM binding to nNOS and iNOS target peptides (Zoche et al., 1996) 
(b) FRET and stopped-flow spectroscopy studies on Alexa-350 labelled T34C/T110W CaM binding to 
NOS target peptides (Wu et al., 2011) 
(c) Competition assays of nNOS activity inhibition by eNOS and iNOS peptides (Venema et al., 1996) 
 
2.1.1 CaM Mutants  
A common strategy used in binding studies is the comparison of native proteins with mutated versions to 
observe how different modifications affect the protein-protein interactions. The use of CaM mutants in 
this particular binding study can help us understand and characterize the overall control that CaM 
structures play in terms of NOS activity. We conducted three different studies using three different mutant 
constructs which include CaM chimeric hybrids (Newman et al., 2004), CaM truncations (Spratt et al., 
2006) and CaM single-point mutations (Spratt et al., 2008). All mutant constructs are described in more 
detail below (Section 2.1.1.2).  
 
2.1.1.1 Measuring Mutant CaM-Dependent Activation of NOS Enzymes 
A series of spectrophotometric kinetic assays were completed to observe mutant CaM-NOS interactions 
and assess which structural elements within CaM are important for electron transfer. The assays used 
measured three distinct activities associated with NOS: NADPH oxidation, cytochrome c reduction and 
•NO production. These activities were measured using the NADPH oxidation assay, the cytochrome c 





Figure 2.1 - Spectrophotometric kinetic assay methods for NOS activity 
The NADPH oxidation assay (red) measures NADPH utilization through monitoring initial rates of 
NADPH oxidation to NADP+ and H+ in the terminal end of the reductase domain by monitoring the 
decrease in absorbance at 340 nm. The cytochrome c assay (green) measures the initial rates of electron 
transfer from the FAD subdomain to the FMN subdomain via cytochrome c reduction by monitoring 
increase in absorbance at 550 nm. Lastly, the oxyhemoglobin capture assay (blue) can be used to 
indirectly measure the efficiency of electron transfer from the FMN subdomain to the heme catalytic site 
via monitoring the reduction of oxyhemoglobin into methemoglobin observed at an absorbance of 401 
nm. This image is adapted from Spratt (2008).  
In these experiments, controls using wt CaM were completed for each assay and activity rates were 
expressed as a percentage normalized to 100%. The 3 sets of CaM mutants were tested under the same 
conditions as wt CaM controls, where results were expressed as a percentage of relative activity compared 
to CaM controls. Interestingly, the cumulative results from these activity studies revealed how different 
regions within CaM play an important role in NOS enzymatic activity. These studies revealed major 
differences between CaM control over cNOS isozymes vs. iNOS enzymes.  
 
2.1.1.2 Calmodulin Troponin C Chimera Mutants 
As mentioned in Section 1.3, CaM binds Ca2+ through 4 highly conserved EF-hand motifs. The binding 
and activation of CaM’s protein targets are regulated through the binding of Ca2+. A structurally similar 
Ca2+-binding protein akin to CaM is cardiac troponin C (TnC), a protein responsible for the activation of 
thin filament cardiac muscle (Schreier et al., 1990).  Although both proteins consist of 2 globular domains 
linked by a central helix region, TnC has seven more N-terminal and three more central helix residues 
than CaM (George et al., 1993). CaM and TnC share approximately 70% sequence homology, where the 
local structures within EF-hands 1, 3 and 4 are highly conserved but the difference in sequence found in 
EF-hand 2 of TnC causes a difference in overall structure of the protein (Figure 2.2.A) (Sia et al., 1997; 
Su et al., 1995).  
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   (A) 
 
  (B) 
 
Figure 2.2 - CaM-TnC chimera constructs 
(A) A sequence alignment of CaM and TnC according to similarities in primary amino acid sequence and 
secondary structure. Locations of the EF-Hand domains, subdomain loops and helices are indicated. 
Residue numbers are indicated below the sequences. The central helices of CaM and TnC are indicated. 
The arrows indicate splice points used to make chimeric mutants. Reprinted from Su et al. 1995. (B) A 
cartoon depiction of chimeric CaM-TnC mutant proteins aligned according to EF-Hand domains (in 
roman numerals). CaM portions are shown in red and TnC portions in blue. EF hands motifs are shown as 
crescents. The small numbers show the corresponding amino acid residues from each respective protein. 
This figure is adapted from Spratt (2008).  
 
Another major difference observed is the affinities of each EF-hand for Ca2+; most notable is the 







I I III I
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Importantly, TnC proteins are unable to activate CaM-dependent enzymes (George et al., 1993). Due to 
their overall EF-hand structural similarities, chimeric proteins were developed, replacing individual EF-
hand domains from CaM with the corresponding EF-hand domains from TnC (Figure 2.2.B). This set of 
mutants was constructed by Su et al. (1995). Through the replacement of each domain within each 
specific construct, the function of the specific EF-hand was effectively removed. To investigate the role 
and importance of each individual EF-hand during NOS catalysis, Newman et al. (2004) studied the 
CaM-TnC dependent activation of NOS enzymes (Table 2.2). Presented below is the summary of the 
activity kinetic results from the CaM-TnC activation of NOS enzymes 
Table 2-2 - Activity Profiles of CaM-TnC Binding to NOS Enzymes 
 
A study of CaM-TnC chimera activation of NOS enzymes (Newman et al., 2004). 
All assays were performed @ 25 °C, in the presence of 2 μM wt CaM or CaM mutant and either 200 μM 
CaCl2 or 250 μM EDTA as indicated, unless otherwise specified. All values are expressed as a % relative 
to wt CaM controls for each set of mutants. NAA = No Apparent Activity. 
 
Activities of nNOS bound to wt CaM were 148 min-1 (NADPH oxidation), 1163 min-1(Cyt c reduction), 
40 min-1 (•NO production).  
Activities of eNOS bound to wt CaM were 31 min-1 (NADPH oxidation), 70 min-1(Cyt c reduction), 10 
min-1 (•NO production).  
Activities of iNOS bound to wt CaM were 77 min-1 (NADPH oxidation), 1395 min-1(Cyt c reduction), 47 
min-1 (•NO production). 
Data is adapted and summarized from Newman et al. (2004).  
CaM 
Construct 



















wt CaM 100  3 100  4 100  5 100  4 100  3 100  3 
wt CaM 
(EDTA) 
NAA NAA NAA 4  1 6  1 8  2 
CaM-1TnC 12  1 5  1 7  4 28  2 67  3 17  2 
CaM-2TnC 89  3 102  2 108  5 101  3 27  1 56  1 
CaM-3TnC 22  3 75  2 20  2 47  4 87  3 31  1 
CaM-4TnC 23  4 102  4 17  2 47  3 71  1 39  3 
 Inducible NOS 














wt CaM 100  2  79  6 100  3 92  1 100  2 66  2 
CaM-1TnC 131  1 76  3 160  7 131  7 123  4 71  4 
CaM-2TnC 79  3 35  5 141  5 161  4 58  4 4  1 
CaM-3TnC 93  6 38  8 145  6 98  2 109  5 18  1 
CaM-4TnC 90  3 89  6 113  6 101  2 115  3 72  4 
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2.1.1.3 Calmodulin EF-Hand Pair Mutants  
CaM is made up of 2 globular N- and C-terminal domains with an EF-hand pair within each domain. To 
investigate the contribution of each EF-hand pairs in regards to the binding and activation of various 
target proteins, including NOS enzymes, a set of mutants was developed by the Persechini group (1994; 
1996) containing 4 different constructs (Figure 2.2). This includes single EF hand pairs (nCaM and 
cCAM) and duplicated EF Hand pairs (CaMNN and CaMCC).  
 
Figure 2.3 - CaM EF-hand pair constructs 
(A) A ribbon structure showing holo CaM (1CLL). The N-terminal, C-terminal and linker region are 
colored in blue, red and grey, respectively. (B) A cartoon depiction of single EF-hand pair mutants, nCaM 
in blue (residues 1-81) and cCaM in red (residues 76-148) (Anthony Persechini et al., 1994). EF-Hand 
motifs are shown as crescents. (C) A cartoon depiction of duplicated EF-hand pair mutants, CaMNN in 
blue (residues 1-81, 76-81, 9-75) and CaMCC in red (1-8, 82-148, 76-81, 76-148) (Persechini et al., 
1996). EF-Hand motifs are shown as crescents.  
Single EF-hand pair mutants (Figure 2.2.B) are truncations of the wt CaM protein (Figure 2.2.A) 
where the name denotes the respective globular domain. The nCaM construct employed in these studies 
has a slight modification where the central linker region has been included (i.e. residues 1-81) whereas the 
original nCaM construct used by Persechini et al. (1994) did not contain the central linker region (i.e. 
residues 1-75). However, previous work from our lab has shown that the addition of the central linker 
region does not affect the ability of the nCaM to bind to its target (Spratt et al., 2006). The duplicated EF-
hand pair mutants in Figure 2.2.C are the result of the fusion of the single EF-hand pair mutants.  
Unlike the CaM-TnC constructs, this set of mutants was used to investigate the role and importance 
of the associated EF-hand pairs within the 2 terminal globular domains. Similar to the previous 
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investigation, Spratt et al. (2006) studied the CaM EF-hand pair dependent activation of NOS enzymes 
Table 2.3). Presented below is the summary of the activity kinetic results from the CaM EF-hand pair 
activation of NOS enzymes. 
Table 2-3 - Activity Profiles of CaM EF-Hand Pairs Binding to NOS Enzymes 
  
A study of EF-hand pair mutant activation of NOS enzymes (Spratt et al., 2006).  
All assays were performed @ 25 °C, in the presence of 2 μM wt CaM or CaM mutant and either 200 μM 
CaCl2 or 250 μM EDTA as indicated, unless otherwise specified. All values are expressed as a % relative 
to wt CaM controls for each set of mutants. NAA = No Apparent Activity. 
 
Activities of nNOS bound to wt CaM were 142 min-1 (NADPH oxidation), 917.5 min-1(Cyt c reduction), 
45.5 min-1 (•NO production).  
Activities of eNOS bound to wt CaM were 30 min-1 (NADPH oxidation), 50.7 min-1(Cyt c reduction), 11 
min-1 (•NO production). 
Activities of iNOS bound to wt CaM were 101 min-1 (NADPH oxidation), 1397min-1(Cyt c reduction), 
47 min-1 (•NO production). 
Data is adapted and summarized from Spratt et al. (2006).  
 
2.1.1.4 Calmodulin Phosphomimetic Mutants 
CaM has been found to be phosphorylated within the central linker in vivo by casein kinase II (CK-II) 
(Quadroni et al., 1994). The central linker is believed to be important in the activation of various target 
CaM 
Construct 



















wt CaM 100  2 100  6  100  5 100  4  100  2 100  2 
wt CaM 
(EDTA) 
6  3 NAA NAA NAA NAA NAA 
nCaM 6  2 37  3 NAA 5  3 17  1 5  1 
cCaM 4  3 NAA NAA NAA NAA NAA 
CaMNN 93  4 90  5 81  3 115  4 111  3 98  4 
CaMCC 5  2 NAA NAA 4  3  43  1 17  3 
 Inducible NOS 














wt CaM 100  4 96  6 100  2 94  1 100  2 66  2 
nCaM 80  7 28  3 109  3 115  2 71  2 NAA 
cCaM 44  3 20  3 62  1 77  2 12  1 NAA 
CaMNN 48  3 58  3 133  4 133  1 74  7 23  1 
CaMCC 75  1 38  3 69  2 82  3 54  1 7  1 
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proteins (Persechini et al., 1989). Post-translational modifications at these sites are important in the 
regulation of CaM’s activity, and thus, the regulation of NOS enzymes. Studying these modifications 
however are hard due to the difficulty individually phosphorylating single amino acids. Therefore, to 
study the role of post-translational modifications of CaM and its effect on NOS function, specific amino 
acids were mutated into an aspartic or glutamic acid residues to mimic the effects of post-translational 
phosphorylation, yielding the phosphomimetic CaM mutants (Figure 2.3).  
 
 
Figure 2.4 - CaM phosphomimetic constructs 
A ribbon structure displaying the peptide backbone of holo CaM (PDB 1CLL) with the mutation sites 
used to yield phosphomimetic CaM constructs highlighted to demonstrate their respective locations: 
T79D (red), S81D (yellow), Y99E (green) and S101D (orange). The protein backbone is shown in blue 
and Ca2+ atoms are depicted as grey spheres. This image was created and viewed using UCSF Chimera 
and adapted from Spratt et al. (2008).  
The amino acid residues threonine 79 and serine 81, two of the residues within the central linker 
modified by CK-II (Quadroni et al., 1994), were mutated into aspartic acid residues. These yielded the 
phosphomimetic mutants, CaM T79D and CaM S81D, along with a combination of the two, CaM 
T79D/S81D (Spratt et al., 2008). Interestingly, phosphorylation of 2 sites flanking the central linker, 
tyrosine 99 (Mishra et al., 2010) and serine 101(Greif et al., 2004), were reported to affect the activity of 
NOS specifically and therefore, phosphomimetic mutant constructs Y99E and S101D were also 
developed and studied. Similar to the previous sets of mutants, Spratt et al. (2008) studied the 
phosphomimetic CaM-dependent activation of NOS enzymes (Table 2.4). Presented below is the 





Table 2-4 - Activity Profiles of Phosphomimetic CaM Mutants Binding to NOS Enzymes 
 
All assays were performed @ 25 °C, in the presence of 2 μM wt CaM or CaM mutant and either 200 μM 
CaCl2 or 250 μM EDTA as indicated, unless otherwise specified. All values are expressed as a % relative 
to wt CaM controls for each set of mutants. NAA = No Apparent Activity. 
A study of CaM phosphomimetic mutant activation of NOS enzymes (Spratt et al., 2008).  
Activities of nNOS bound to wt CaM were 132 min-1 (NADPH oxidation), 1253 min-1(Cyt c reduction), 
36 min-1 (•NO production).  
Activities of eNOS bound to wt CaM were 27 min-1 (NADPH oxidation), 71.1 min-1(Cyt c reduction), 9 
min-1 (•NO production). 
Activities of iNOS bound to wt CaM were 1486 min-1 (NADPH oxidation), 82.4 min-1(Cyt c reduction), 
50 min-1 (•NO production). 
Data is adapted and summarized from Spratt et al. (2008).  
 
2.1.2 Using Surface Plasmon Resonance to Investigate the CaM-NOS Interaction 
The previous studies from Section 2.1.1 have suggested possible effects different regions within CaM 
have on the activation of •NO production in NOS isozymes by observing activation rates. These studies 
gave more insight about the dynamic interplay that can occur between CaM and NOS. Binding rate 
constants and affinities for the mutant CaM proteins detailed in Section 2.1.1 interacting with CaM-
binding site peptides of NOS enzymes, have not yet been determined.  
CaM 
Construct 



















wt CaM 100  4 100  3 100  2 100  1 100  4 100  2 
wt CaM 
(EDTA) 
13  4 9  1 NAA 15  3 9  3 NAA 
CaM-1TnC 93  3 105  3 94  3 105  3 86  4 108  3 
CaM-2TnC 89  5 106  5 89  3 107  4 84  5 106  2 
CaM-3TnC 97  2 111  2 76  3 99  2 80  1 102  3 
CaM-4TnC 80  3 99  3 80  2 100  2 86  4 82  5 
 Inducible NOS 














wt CaM 100  3 86  4 100  4 84  5 100  4 87  2 
T79D 106  1 95  2 120  4 131  7 123  4 71  4 
S81D 104  1 103  3 169  3 161  4 58  4 4  1 
T79D 
S81D 
102  1 98  3  149  1 98  2 109  5 18  1 
S101D 103  3 97  3 153  3 101  2 115  3 72  4 
 
 24 
A study by Zoche et al. (1995) investigated the binding of wt CaM to peptides representing the 
CaM-binding domains nNOS and iNOS and determined both binding rate constants and dissociation 
constants for both isozymes using traditional SPR. Similarly, this current study will aim to determine the 
same binding parameters as those determined by Zoche et al. (1995) for the aforementioned CaM mutants 
(Section 2.1.1) binding to all 3 NOS peptide sites of all three NOS isozymes using a modified SPR 
method known as localized SPR (L-SPR) spectroscopy (Figure 2.6) (2.1.2.1). The results from this SPR 
study will be used to supplement the activity data acquired from past activity experiments (Section 2.1.1). 
We hope to correlate the binding kinetics from this SPR study with the activity profiles from the assay 
studies and see if there is a direct relationship between the affinity of CaM protein and the activation of 
NOS activity.  
 
2.1.2.1 Localized Surface Plasmon Resonance  
SPR is an emerging technique to study the thermodynamics and kinetics of biological binding processes 
(Piliarik et al., 2009). The most popular commercially available SPR instrument used today is the 
BIAcore. With traditional SPR experiments, continuous metal films are used as the sensing platform for 
propagating plasmons (Section 1.3). However, with recent advances in science and engineering, the 
ability to control the fabrication and manipulation of metallic structures on the nanoscale has paved the 
way for the development of new sensing platforms that utilize small metal nanoparticles instead of 
continuous films (Haes & Van Duyne, 2004).  
Compared to metal films, the light used to stimulate the surface interacts with nanoparticles much 
smaller than the incident wavelength, leading to plasmons that oscillate locally around the particle with a 
frequency known as the L-SPR (Haes & Van Duyne, 2004). Similar to its traditional predecessor, L-SPR 
spectroscopy can provide thermodynamic and real-time kinetic data for bimolecular interactions. 
Although traditional SPR sensors provide higher sensitivity to changes in the bulk refractive index than 
L-SPR sensors (Figure 2.5), the response from both methods are comparable. This is a result of smaller 
sensing volumes offered in L-SPR sensors due to a 40-50 times reduction in the electromagnetic (EM)-




Figure 2.5 - SPR sensors VS. L-SPR sensors 
Schematic diagram illustrating the benefits of L-SPR, highlighting the key differences in terms of metal 
surface composition, response sensitivity to bulk effects and the length of electromagnetic field decay. 
This figure was reprinted with permission from Nicoya Lifesciences Inc. ©2016.  
Moreover, L-SPR produces a strong resonance absorbance peak in the visible range of light, with 
its position highly sensitive to the local refractive index surrounding the particle (Figure 2.5). Therefore, 
L-SPR typically senses small changes in the wavelength of the absorbance position, rather than the angle 
as with traditional SPR (Willets & Van Duyne, 2007). Another advantage that LSPR sensors offer is that 
they can be manufactured at a more affordable price than current commercial SPR instruments on the 
market (Haes & Van Duyne, 2004). The hardware needed for L-SPR sensors is less complex as no prism 
is needed to couple the light, as well as no strict temperature control. This simplifies the instrument as it 
can be made smaller as well as making them more robust against vibrational and mechanical noise. 
Furthermore, the utilization of nanoparticles instead of continuous metal films leads to cheaper 
manufacturing costs of sensor chips (Willets & Van Duyne, 2007). With this is mind, this SPR study was 
completed in partnership with Nicoya Lifesciences Inc., developers and manufacturers of the benchtop L-





2.2 Experimental Procedures 
 
2.2.1 Expression of Wild-Type CaM 
pET9dCaM plasmid (Appendix B) was transformed into BL21 (DE3) E. coli cells using electroporation 
with Eppendorf Electroporator (insert specifics here). Transformants were plated onto ampicillin-selective 
lysogeny broth (LB) media and grown overnight for 16 hrs. Individual colonies from overnight plates 
were used to inoculate 2 x 50 mL ampicillin-selective terrific broth (TB) media in 250 mL flasks and 
grown overnight at 37 °C, 200 rpm. 25 mL of overnight starter culture was used to inoculate 2 x 1 L 
ampicillin-selective TB media. 1 L cultures were grown at 37 °C, 200 rpm, to an optical density (OD) at 
600 nm of 0.6 - 0.8 and protein expression was induced with 500 μM isopropyl B-D-1-
thiogalactopyranoside (IPTG). Cells were harvested after 3 – 4 hours of expression by centrifugation at 
6000 x g at 4 °C for 5 minutes, flash frozen and stored at -80 °C.  
 
2.2.2 Purification of Wild-Type CaM 
Cells were thawed on ice and resuspended in 4 volumes of 50 mM Tris-HCl, 100 mM NaCl, 1 mM 
dithiothreitol (DTT) with an addition of a cOmplete protease inhibitor cocktail tablet (Roche). Cells were 
lysed by homogenization using an Avestin EmulsiFlex-C5 homogenizer (Ottawa, ON). Extra cellular 
debris was clarified by centrifugation at 48,000 x g for 30 mins at 4 °C and the supernatant was collected. 
The protein was purified using a phenyl sepharose column (GE Healthcare Life Science) on the 
AKTAFPLC (GE Healthcare Life Science). The column was equilibrated with 5 column volumes of 
Buffer A (50 mM Tris-HCl, 1 mM CaCl2, pH 7.5, 4 °C). Calcium chloride (CaCl2) was added to the 
supernatant to a concentration of 5mM to saturate CaM with Ca2+ and expose hydrophobic patches and 
ensure interaction with the phenyl sepharose resin. The Ca2+-saturated solution was loaded fully onto the 
column at a rate of 1 mL/min and the column was washed using Buffer A. This was followed with 2 
rounds of washes using Buffer B (50 mM Tris-HCl, 500 mM NaCl, 1 mM CaCl2, pH 7.5, 4 °C) to remove 
any non-specific proteins binding to the resin and then Buffer A again to remove NaCl. The CaM proteins 
were then eluted from the phenyl sepharose column using Buffer C (10 mM Tris-HCl, 10 mM EDTA, pH 
7.5, 4 °C) and 1 mL fractions were collected and pooled. 
Pooled fractions were scanned from 350 – 250 nm on a Cary 4000 UV-visible spectrophotometer 
(Varian, Mississauga, ON). The collected fraction should show characteristic absorbance peaks of CaM at 
277 nm (tyrosine residues) and 269, 265, 259 and 253 (phenylalanine residues). The pooled fractions 
were dialysed overnight against 1 L of Buffer A using 6-8000 MWCO dialysis tubing (VWR 
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International, Mississauga, ON). Dialysis tubing was prepared in boiling MQH2O with addition of sodium 
bicarbonate and a pinch of EDTA for 10-15 minutes and rinsed thoroughly with MQH2O. Dialyzed 
fractions were scanned once again to determine the concentration of the purified CaM using the ε277 of 
3029 M-1cm-1 for CaM saturated with Ca2+. The purified CaM was aliquoted in 100 μL fractions, flash 
frozen and stored at -80 °C. 
 
2.2.3 Expression and Purification of EF-Hand Pair CaM Mutants 
EF Hand mutant proteins were expressed in BL21 (DE3) E.coli cells transformed with pnCaMChlor, 
pcCaMKan, pCaMNNKan and pCaMCCKan Appendix A) plasmids prepared by previous members of 
our lab. Protein sequences are outlined in Figure 2.2. The expression procedure was the same as 
previously described for wild-type CaM (section 2.2.1). 
 
2.2.4 Expression and Purification of CaM-TnC Chimeras  
CaM-TnC proteins were expressed in BL21 (DE3) E.coli cells transformed with pCaM-1TNCKan, 
pCaM-2TNCKan, pCaM-3TNCKan and pCaM-4TNCKan plasmids subcloned by previous members of 
our lab (Appendix B). The expression procedure was the same as previously described for wild-type CaM 
(section 2.2.1). 
EF Hand mutant CaM proteins were purified as previously described for wild-type CaM (section 
2.2.2).   
 
2.2.5 Expression and Purification of CaM Phosphomimetic Mutants  
CaM phosphomimetic mutant proteins were retrieved from stocks expressed and purified by 
previous members of our lab. These mutants were expressed and purified as previously described in 
Spratt et al. (2008)  
 
2.2.6 Characterization of CaM Mutants 
All CaM proteins were characterized using ultraviolet-visible (UV-Vis) spectroscopy (Section 
2.2.1), sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), electrospray ionization - 




2.2.6.1 Mass Spectrometry  
ESI-MS was done using a Quadrupole Time-OF-Flight (QTOF) spectrometer (Micromass, Mancheser, 
UK) on all purified CaM mutants as well as retrieved CaM phosphomimetic mutants to ensure the 
absence of posttranslational modifications on CaM proteins and the correct size of protein. CaM mutants 
were prepared for ESI-MS by buffer transfer into water using a Y3000 centrifugual filter device 
(Millipose, Millerica, MA, USA) and then diluted using a 1:1 CH3OH:H2O containing 0.1% formic acid 
to a concentration of approximately 5-10 pmol in 300 μL. The samples were infused at 10 μL/min. Raw 
data (m/z) was collected and then run through deconvolution software to yield spectra with a true 
molecular mass scale.  
 
2.2.7 Surface Plasmon Resonance Spectroscopy of CaM Proteins with NOS Peptides 
SPR analysis was completed using the OpenSPR by Nicoya LifeSciences (Waterloo, ON, Canada) 
(Appendix B) at 25 °C with a 100 μL loading loop.  
 
2.2.7.1 SPR Chip Preparation for cNOS Peptide Immobilization on Standard Gold Chips 
The interaction of CaM proteins with cNOS peptides were completed using a standard gold sensor chip 
(Appendix B). Gold chips were rinsed with ethanol, followed with acetone and finally isopropanol. The 
gold chip was soaked in an isopropanol (IPA) bath in a petri dish for 5 minutes and subsequently dried 
with filtered air using a syringe filter. The chip was then treated with a 7:3 piranha acid solution1 (sulfuric 
acid to 30% hydrogen peroxide) for 10 minutes in another petri dish. The reaction was quenched with 
MQH2O. The chip was rinsed with MQH2O to remove any traces of acid on the surface, followed with an 
ethanol rinse. Lastly, the chip was submerged in an ethanol bath for a minimum of 2 hours before use.  
 
2.2.7.2 SPR Chip Preparation for iNOS Peptide Immobilization on Streptavidin-
Functionalized Gold Chips 
The interaction of CaM proteins with iNOS peptides were completed using a streptavidin functionalized 
sensor chip. The streptavidin chip was rinsed with cold MQH2O and dried with filtered air using a syringe 
filter.  
                                                      
1 *WARNING*: Piranha acid is a strong oxidizer. Both liquid and vapour forms are highly corrosive to skin and 
respiratory tract. Direct contact can be extremely destructive to mucous membranes, upper respiratory tract, eyes 
and will cause skin burns. Review MSDS and ensure proper safe work practices and training before use. 
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2.2.7.3 Binding Kinetic Analysis of CaM Proteins and Immobilized cNOS Peptides 
nNOS & eNOS CaM-binding domain peptides were ordered (CanPeptide, Quebec) containing an –SH 
terminal (Table 2.2). The OpenSPR was run at 150 µL/min with phosphate-buffered saline (PBS) (1X 
PBS, pH 7.5) equilibration buffer and a dark/light reference was taken with a blank gold chip. A newly 
prepared chip (Section 2.1.7.1) was loaded into the sample holder for equilibration for approximately 10 
minutes to stabilize the baseline. 80% IPA was loaded and injected for 10 seconds (referred to as a pulse 
injection) to remove any air bubbles in the system. The pump speed was reduced to 50 µL/min. cNOS 
peptides were immobilized onto the gold surface by injecting a solution of 5:1 cysteamine to cNOS 
peptide in PBS equilibration buffer.2 Cysteamine was added as a blocking agent to ensure adequate 
spacing between peptides.  
Table 2-5 - NOS CaM-binding domain peptide sequences 
NOS 
Peptide 
Sensor Chip Protein Sequence (Nterminal  Cterminal) 
nNOS Standard Gold  KRRAI – GFKKL – AEAVK – MGQAM – AKRVC  
eNOS Standard Gold  TRKKT – FKEVA – NAVKI – SASLM - C 
iNOS Streptavidin Biotin – GSGGG- GRRWI –PLKVL –VKAVL – FACML –MRK 
This table displays the protein sequences of the 3 peptide ligands used in this SPR study. The binding 
elements used to bind onto the sensor chip surface are highlighted in red. Sensor chips were provided by 
Nicoya Lifesciences.  
Several injections of 1 mM cysteamine in equilibration buffer were done to saturate the rest of the 
surface and prevent non-specific binding (NSB). After each injection, equilibration buffer was pumped 
for approximately 10 minutes or until the response signal was stabilized.  The inlet line was switched into 
PBS analyte buffer (1X PBS, pH 7.5 + 0.1 mM CaCl2) and buffer was allowed to flow until the signal 
reached a new baseline. A range of decreasing wt CaM concentrations (500-25 nM) were prepared and 
injected in analyte buffer (association phase). After each injection of sample, analyte buffer was pumped 
for approximately 8-12 minutes or until the response signal was stabilized (dissociation phase). An 
injection of regeneration buffer (1X PBS, pH 8.0 + 10 mM EDTA) in between analyte concentrations was 
done to fully dissociate any remaining bound CaM proteins from the peptide surface and to bring the 
signal back to baseline (regeneration phase). A blank injection of analyte buffer was done at the end to 
measure the background signal. Analysis of the the data and calculations of the kinetic parameters were 
done using TraceDrawer software as recommended by the manufacturer. The system was cleaned as 
recommended by the manufacturer.  
                                                      
2 NOTE: The sample line was purged with buffer and air after each injection to prevent the contamination and 
diffusion of the succeeding injections into the new sample being loaded. 
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2.2.7.4 Binding Kinetic Analysis of CaM Proteins and Immobilized iNOS Peptide 
iNOS CaM-binding domain peptide was ordered with a biotin label (CanPeptide Inc., Quebec, Canada) 
(Table 2.2). The OpenSPR was run at 150 µL/min with 3-N-morpholinopropane-1-sulfonic acid (MOPS) 
analyte buffer (30 MOPS, 100 mM KCl, 0.1 mM CaCl2, pH 7.5) and a dark/light reference was taken 
with a blank gold chip. A newly prepared chip (Section 2.1.7.2) was loaded into the sample holder for 
equilibration for approximately 10 minutes to stabilize the baseline. A pulse injection of 80% IPA was 
done to remove any air bubbles in the system. The pump speed was reduced to 50 µL/min and a 50 μg/μL 
solution of iNOS peptide was prepared and injected for immobilization. The analyte buffer was pumped 
for approximately 10 minutes or until the response signal was stabilized. A range of decreasing wt CaM 
concentrations (500-25 nM) were prepared and injected in analyte buffer (association phase). After each 
injection of sample, analyte buffer was pumped for approximately 8-12 minutes or until the response 
signal was stabilized (dissociation phase). An injection of regeneration buffer (10 mM HCl) in between 
analyte concentrations was done to fully dissociate any remaining bound CaM proteins from the peptide 
surface and to bring the signal back to baseline (regeneration phase). A blank injection of analyte buffer 
was done at the end to measure the background signal. Analysis of the the data and calculations of the 
kinetic parameters were done using TraceDrawer software as recommended by the manufacturer. The 













2.3.1 Protein Expression, Purification, And Characterization  
Each of the CaM proteins were expressed and purified with the exception of CaM phosphomimetic 
mutants, which were retrieved from old stocks from Spratt et al, (2008). Purified CaM proteins were 
analyzed by SDS-PAGE.  
 
Figure 2.6 - SDS-PAGE of CaM EF-hand pair mutants 
The purified EF-hand CaM mutants were run on a 15% SDS-polyacrylamide gel. 10 ug of each protein 
was loaded into an SDS buffer containing 5% BME. Lane 1: Low molecular mass protein standard (Bio 
Rad); Lane 2: wt CaM; Lane 3: nCaM; Lane 4: cCaM; Lane 5: CaMNN; Lane 6: CaMCC. Key protein 
size markers are labelled on the side 
 
SDS-PAGE analysis of CaM EF-Hand pairs displayed the proper size and were judged to be >95% 
homogenous. Smudging seen on wt CaM and cCaM can be attributed to artifacts from running the 
procedure.   


























Figure 2.7 - SDS-PAGE of CaM-TnC chimeric mutants 
The purified TNC Chimeric mutants were run on a 15% SDS-polyacrylamide gel. 10 ug of each protein 
was loaded into an SDS buffer containing 5% BME. Lane 1: Low molecular mass protein standard 
(Bioshop); Lane 2: wt CaM; Lane 3: 1TnC; Lane 4: 2TnC; Lane 5: 3TnC Lane 6: 4TnC. Key protein size 
markers are labelled on the side 
 
SDS-PAGE analysis of TnC chimeric proteins displayed the proper size were judged to be >95% 















Figure 2.8 - SDS-PAGE of CaM phosphomimetic mutants 
The purified central linker mutants were run on a 15% SDS-polyacrylamide gel. 10 ug of each protein 
was loaded into an SDS buffer containing 5% BME. Lane 1: Low molecular mass protein standard (Bio 
Rad); Lane 2: wt CaM; Lane 3: CaM T79D; Lane 4: CaM T79D/CaM S81D; Lane 5: CaM S81D; Lane 6: 
CaM S101D; Lane 7: Y99E. Key protein size markers are labelled on the side 
 
SDS-PAGE analysis of retrieved phosphomimetic CaM mutants displayed appropriate banding patterns 
and CaM proteins were judged to be >95% homogenous. Splaying of the ladder in Lane 1 is an artifact 
from running the procedure.  
All CaM proteins sizes were further verified using ESI-MS to rule out any modifications (Table 





















   
wt CaM 16.706 16.705 
nCaM 8.317 ---(c) 
cCaM 8.408 8.407 
CaMNN 16.379 16.378 
CaMCC 17.033 17.032 
1-TnC 17.796 17.794 
2-TnC 17.273 17.269 
3-TnC 16.732 16.731 
4-TnC 16.894 16.893 
T79D 16.720 16.719 
S81D 16.734 16.733 
T79D / S81D 16.748 16.747 
Y99E 16.672 16.674 
S101D 16.734 16.733 
(a) – Masses of deconvoluted ESI-MS spectra are accurate to within 4-5 Da.  
(b) – Calculated mass based on amino acid sequence 
(c) – Spectra could not be deconvoluted. Analysis of size was confirmed through SDS-PAGE.  
 
As a secondary test to confirm the validity of retrieved phosphomimetic CaMs, 
spectropolarimetry was employed. All CaM proteins displayed α-helical content expected of CaM 
proteins, indicated by peaks at 208 and 222 nm. (Results not shown).  
Due to the differences observed in Ca2+ dependency and immobilization methods between cNOS 
enzymes vs. iNOS enzymes, the L-SPR binding kinetic analysis of CaM binding to iNOS peptide was 






2.3.2 L-SPR Binding Kinetic Analysis of CaM Mutant Proteins with cNOS Peptides 
L-SPR was used to monitor real-time binding kinetics of CaM mutant proteins binding with immobilized 
cNOS peptides. The L-SPR response was observed via a sensogram, which monitors the wavelength of 
the maximum resonance peak vs. time (Figure 2.9). As a set of controls, L-SPR analysis was first 
completed for wt CaM binding to both nNOS and eNOS peptides.  
The first step involved the immobilization of the cNOS peptide ligand onto the sensor surface. The 
immobilization of cNOS peptides was most optimal when injecting a 5:1 solution of cysteamine blocker 
to NOS peptide into the flow cell, producing a large and rapid response, with an average λ shift of at least 
0.8 nm – 1 nm. This response indicated a strong and successful binding of the peptide to the gold sensor 
surface as a new stable baseline was achieved. Cysteamine was added to ensure adequate spacing in 
between peptides and allow enough space for CaM protein binding. Multiple injections of cysteamine was 
subsequently done to ensure full saturation of all gold nanoparticle sites on the surface (Figure 2.8.A).   
Once the surface was functionalized with the appropriate ligand, the buffer was switched to a Ca2+ 
containing running buffer, ensuring all CaM proteins would be Ca2+ saturated for binding cNOS peptides. 
L-SPR binding analysis occurred in 3 phases: an association phase, a dissociation phase and a 
regeneration phase. wt CaM prepared in the Ca2+ running buffer was injected in decreasing concentrations 
from 500 nM – 50 nM for the association phase. The rapid response upon exposure of wt CaM on the 
surface indicated strong 1:1 CaM:cNOS peptide complex formation (Figure 2.8.B). For the dissociation 
phase, the sensor surface was washed and equilibrated with Ca2+ running buffer removing any non-
specific and/or weakly bound CaM protein first. The dissociation of the CaM-peptide complex is 
illustrated by the slow decrease in response over time (Figure 2.8.B). Lastly, 10 mM EDTA was injected 
for the regeneration phase, chelating all Ca2+ ions from remaining bound CaM, disrupting CaM’s ability 
to bind the peptide and completely regenerating the ligand-bound surface as seen by the return of the 
sensogram back to baseline. The association, dissociation and regeneration phases were repeated for all 
concentrations of CaM (Figure 2.8.B). For both cNOS peptides CaM binding, a concentration-dependent 










Figure 2.9 - L-SPR Analysis of wt CaM 
A typical L-SPR analysis of CaM proteins with immobilized cNOS peptides (A) Immobilization of peptide ligands on   a 
nanogold chip. Amount of ligand binding is assessed by the change in baseline. (B)  CaM analyte injections at decreasing 
concentrations. Association, dissociation and regeneration phases are seen in real-time. (C) Kinetic analysis of L-SPR 
data using Tracedrawer. Data was fit according to a 1:1 binding model







Lastly, the kinetic parameters were determined by post-analysis of L-SPR data. The sensogram was 
exported into Tracedrawer software, a curve-fitting program, (Figure 2.8.C). The average measured 
wavelength of all analyte injections were set to a value of 0 and overlayed on top of each other to 
compare the phases of SPR binding. The datasets were fit according to a 1:1 binding model, unless 
otherwise stated, where the binding rate parameters, ka and kd, the association and dissociation rate 
constants (also known as kon and koff) and KD, the dissociation constant, were determined. For 
conventional purposes, we will now refer to rate constant parameters as kon and koff for the remainder 
of this thesis. 
We determined kon = 9.77 (± 0.03) x 10
4 M-1s-1 and koff = 14 (± 0.003) x 10
-4 s-1 for wt CaM 
bound to the nNOS peptide. The dissociation constant KD, a ratio of kd / ka, was 14.4 (±0.09) nM. 
Changes in cNOS peptide concentration immobilized on the surface did not overtly affect the kinetic 
parameters. These results were not consistent with traditional SPR experiments observed by Zoche et 
al, (1996) where they determined kon = 1.58 x 10
5 M-1s-1, koff = 17.87 x 10
-4 s-1 and KD = 5.0 for wt 
CaM bound to the nNOS peptide (Table 2.1). In comparison, traditional SPR analysis yielded a larger 
kon, resulting in an overall smaller KD, with a difference of approximately 9 nM compared with the L-
SPR value. However, the difference in kinetic parameters between the traditional vs localized 
methods can be attributed to the longer EM-field-decay length of metal films in traditional SPR 
sensors vs. the shorter EM-field-decay length of nanoparticles in L-SPR sensors (Section 2.1.2.1). 
The decrease in surface height of nanoparticles vs. continuous metal films is also known to increase 
the overall sensitivity of the SPR response (Yonzon et al., 2004).  
This is the first time kinetic parameters have been reported for CaM bound to the eNOS peptide 
using an L-SPR method. We report the values of kon = 15.8 (± 0.02) x 10
4 M-1s-1, koff = 18.9 (±0.001) 
x 10-4 s-1, and a dissociation constant KD of 12.0 (±0.17) nM for wt CaM bound to the eNOS peptide. 
The binding parameters determined here for CaM and eNOS peptide via L-SPR are largely different 
than those determined through fluorescence experiments by Wu et al. (2011), where they reported: kon 
= 2.9 x 108 M-1s-1, koff = 4.5 s
-1 and a KD of 1.6. The difference in values between these two methods is 
most likely due to different experimental methods. Despite the differences between different methods, 
the order of binding affinity is the same: CaM binds the eNOS peptide tighter than the nNOS peptide 





2.3.3 Binding Interactions Between CaM Mutants and cNOS Peptides  
After wt CaM controls were established, the procedure was repeated for all CaM mutant proteins 
binding to both cNOS peptides. This study is the first report of kinetic parameters derived for TnC 
chimeras, EF-hand pair and phosphomimetic CaM mutants binding to cNOS peptides. The kinetic 
rate constants, kon & koff, as well as the dissociation constant KD, calculated from fitting sensogram 
data with Tracedrawer software, are displayed and summarized in Appendix C. Overall, we measured 
the quality of binding according to the binding dissociation constant, KD, which is inversely 
proportionate to binding affinity, KA. Furthermore, we used the binding rate constants, kon and koff, as 
supplementary values to help explain the quality of binding.  
In addition, as part of our binding interaction analysis, we compared our experimentally 
determined kinetic rate parameters of CaM mutant proteins binding to immobilized cNOS peptides to 
previously determined activity profiles of the same mutant CaM proteins and their ability to activate 
full cNOS activity, using the assay methods mentioned in Section 2.1.1.1 (Newman et al., 2004; 
Spratt et al., 2006, 2008). This comparison is further explained in Section 2.3.3.1. and displayed in 
bar graphs in Section 2.3.3.2 – Section 2.3.3.3.   
 
2.3.3.1 Comparative Analysis of Kinetic Rate Parameters and CaM Mutant Activation 
Profiles 
For our binding analysis, we compared the relative binding and relative activation of mutant CaM 
proteins with respect to wt CaM binding and activation, where binding and activation of wt CaM was 
made to be 100%. The values for relative activation of cNOS enzymes were previously determined 
(Newman et al., 2004; Spratt et al., 2006, 2008) and were attained using Formulas 1-3.  
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Formula 2 - Relative Activity: Cytochrome c Reduction 
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Formula 3 - Relative Activity: •NO production 
(
• NO Production𝑚𝑢𝑡𝑎𝑛𝑡
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Using L-SPR, we were able to determine the binding rate parameters: kon, koff, and KD. We 
expressed our binding results in terms of relative binding, similar to the relative activity outlined in 
Formulas 1-3. Formula 4 was used to determine relative binding in terms of association rate constant, 
kon, whereas formula 5 was used to determine relative binding in terms of dissociation rate constant 
koff. Naturally, a high koff signifies weaker binding, but to display a positive relationship, the inverse 
of koff values were used. Therefore, for our analysis, higher relative binding in terms of koff signifies 
stronger binding as it represents slower dissociation rates. Lastly, our overall quality of binding was 
assessed by comparing relative binding in terms of affinity, KA, where (𝐾𝐴 =  
1
𝐾𝐷
⁄ ) (Formula 6). 
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2.3.3.2 Binding interactions between CaM-TnC Chimeric Mutants and cNOS peptides 
The CaM-TnC proteins displayed varying binding profiles for immobilized nNOS and eNOS 
peptides. Ranking the overall quality of binding in terms of CaM-TnC mutant affinity for 
immobilized nNOS peptides were: 4TnC > wt CaM > 1TnC > 2TnC > 3TnC. Rankings for the 
affinities of CaM-TnC mutants for the immobilized eNOS peptide were: 2TnC > 1TnC > wt CaM > 


















Figure 2.10 – Comparing CaM-TnC Chimera cNOS Activation and cNOS Peptide Binding 
The relative activities for the 3 types are NOS assays are displayed in different shades of blue: 
NADPH oxidation (light blue), cytochrome c reduction (blue), •NO production (navy blue). Relative 
binding is displayed in red: kon(diagonal lines), koff (vertical lines), KD (shaded). nNOS activity and 
binding are displayed at the top and eNOS activity and binding on the bottom. Relative activities were 
determined using Formulas 1-3 and details on activity assays are found in Section 2.1.1.2. Relative 
binding values were determined using Formulas 4-6 and SPR raw data is located in Appendix C and 
analyzed using Tracedrawer software. All TnC protein binding was completed in duplicate. Bar 























Comparing CaM-TnC Chimeras nNOS Activation and 
nNOS Peptide Binding Kinetics
Relative Activity (%) (NADPH oxidation) Relative Activity (%) (Cyt c Reduction)
Relative Activity (%) (•NO Production) Relative Binding (%) (Kon)



















Comparing CaM-TnC Chimera eNOS Activation and 
eNOS Peptide Binding Kinetics
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We predicted that for the interactions yielding greater relative affinity, we would yield an 
association rate constant to dissociation rate constant ratio (kon : koff) <1. The slower the NOS-CaM 
complex dissociates, or the closer the ratio is closer to 0, the stronger the affinity is for that CaM 
construct to the associated peptide. With regards to nNOS peptide binding, we see that the 4TnC 
mutant had greater relative affinity compared to wt CaM, whereas the other TnC mutants displayed 
weaker relative affinity. Contrary to our prediction, we observed kon : koff ratios of 0.6, 3, 4.2 and 5.2 
for 1TnC, 2TnC, 3TnC and 4TnC, respectively. For eNOS peptide binding, 1TnC and 2TnC 
displayed higher overall relative affinity, where 1TnC displayed similar affinity to wt CaM and 2TnC 
displayed 1.7x greater affinity. With respect to the kon : koff rate constant ratio, we determined values 
of 0.3 and 0.2. On the other hand, both 3TnC and 4TnC displayed a substantial decrease in affinity 
compared to wt CaM. Comparing the kon : koff rate constants ratios, we get values of 2.9 and 4.1. 
Overall, the protein interactions of TnC constructs with the eNOS peptide follow the expected trend 
but not with the nNOS peptide. These interactions are further examined in Section 2.4.1.   
 Comparing our CaM-TnC mutant protein binding data with the activity profiles determined 
by Newman et al. (2004), we observed no overall underlying correlation between the relative strength 
of binding of TnC proteins and their relative activities determined in NOS activity assays. For 
example, the 2TnC construct displayed diminished binding in terms of the nNOS peptide and greater 
binding in terms of the eNOS peptide. However, we see greatly diminished activities of eNOS 
enzyme when activated by the same CaM mutant and greater relative activity in the nNOS enzyme. 
We see this mismatch in binding and activity throughout all 4 of the CaM-TnC mutants. These results 
can be explained by the fact that we are specifically only looking at CaM protein binding in terms of a 
small portion of the NOS enzyme, and not the full holoenzyme. In other words, there are elements of 
the NOS enzyme and CaM outside the specific interactions in the NOS-CaM binding domain that 
could stabilize/destabilize the interaction of CaM with NOS that could affect both activity and 
binding. The relationship between cNOS peptide binding and cNOS activation for CaM TnC 
chimeras is further explored in Section 2.4. 
 
2.3.3.3 Binding Interactions Between CaM EF-Hand Pair Mutants and cNOS Peptides 
Compared to the CaM-TnC mutants, the EF-hand proteins showed similar binding profiles for nNOS 
and eNOS peptides. Ranking the overall quality of binding in terms of CaM mutants for immobilized 
nNOS peptides were: CaMNN > wt CaM/CaM CC >> nCaM/cCaM. On the other hand, ranking the 
affinities of EF-hand CaM mutants for the eNOS peptide were: CaMCC > CaMNN > wt CaM >> 






















Figure 2.11 – Comparing CaM EF-Hand Mutant cNOS Activation and cNOS Peptide Binding 
The relative activities for the 3 types are NOS assays are displayed in different shades of blue: 
NADPH oxidation (light blue), cytochrome c reduction (blue), •NO production (navy blue). ). 
Relative binding is displayed in red: kon(diagonal lines), koff (vertical lines), KD (shaded). nNOS 
activity and binding are displayed at the top and eNOS activity and binding on the bottom. Relative 
binding is displayed in red: kon(diagonal lines), koff (vertical lines), KD (shaded). Relative activities 
were determined using Formulas 1-3 and details on activity assays are found in Section 2.1.1.2. 
Relative binding values were determined using Formulas 4-6 and SPR raw data is located in 
Appendix C and analyzed using Tracedrawer software. All TnC protein binding was completed in 
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Comparing EF-Hand Pair Mutant eNOS Activation 
and eNOS Peptide Binding Kinetics
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Interestingly, both single EF-hand mutant constructs, nCaM and cCaM, displayed no significant 
relative binding with both cNOS peptides. In contrast, duplicate EF-hand pair constructs, CaMNN 
and CaMCC, showed significant relative binding. In terms of the nNOS peptide, CaMNN had 1.4x 
greater affinity for the peptide, whereas CaMCC had comparable affinity when compared to wt CaM 
with kon : koff ratios of 2.4 and 0.87. The opposite is observed for the eNOS peptide where we see that 
CaMNN had comparable affinity for the peptide compared to wt CaM, whereas CaMCC displayed 2x 
greater affinity than wt CaM with kon : koff ratios of 3.2 and 0.87. CaMCC followed the expected trend 
where the greater relative affinity is due to having a slower dissociation rate. On the contrary, the 
CaMNN construct displayed strong affinity for both peptides but displayed a higher rate of 
dissociation. These interactions are further examined in sections 2.4.2.  
Comparing our CaM EF-hand pair mutant binding data with the activity profiles determined by 
Spratt et al. (2006), we see a strong correlation between the single EF-hand pair constructs wherein 
the lack of apparent cNOS activity across all 3 assays is associated by the weak affinity of these 
constructs for the peptide. Analysis of the single EF-hand pairs on the SPR displayed initial binding 
during the association phase, but dissociated rapidly as indicated by a very steep drop in response. 
This interaction was almost identical to a bulk shift response and thus could not be properly fitted and 
evaluated using the TraceDrawer software. Therefore, the binding of these constructs was noted as 
NAB (Figure 2.11). Conversely, we do not see the same correlation for the duplicate EF-Hand pairs. 
The mismatch in relative binding compared to relative activity similar to that seen in CaM TnC 
chimeras is observed for the CaMCC construct, but not CaMNN. Similar to the TnC proteins in 
Section 2.3.3.2., we see that for CaMCC, high affinity does not translate into high activity. The same 
caveat applies in this investigation where the binding interactions is limited to only a small portion of 
the cNOS holoenzyme. The relationship between cNOS peptide binding and cNOS activation for 
CaM EF-hand mutants are further explored in Section 2.4.2. 
2.3.3.4 Binding interactions between Phosphomimetic CaM Mutants and cNOS 
peptides 
Similar to the TnC mutants, the phosphomimetic mutants showed varying binding profiles for cNOS 
peptides. Ranking the affinities of phosphomimetic mutants for the nNOS peptide were: wt CaM > 
S81D > S101D / [T79/S81D] > T79D/Y99E. Ranking the affinities of phosphomimetic mutants for 














The relative activities for the 3 types are NOS assays are displayed in different shades of blue: 
NADPH oxidation (light blue), cytochrome c reduction (blue), •NO production (navy blue). nNOS 
activity and binding are displayed at the top and eNOS activity and binding on the bottom. Relative 
binding is displayed in red: kon(diagonal lines), koff (vertical lines), KD (shaded). Relative activities 
were determined using Formulas 1-3 and details on activity assays are found in Section 2.1.1.2. 
Relative binding values were determined using Formulas 4-6 and SPR raw data is located in 
Appendix C and analyzed using Tracedrawer software. All TnC protein binding was completed in 
triplicate. Bar values represent the standard mean deviation. 
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All phosphomimetic proteins in this study displayed lesser relative affinity for both nNOS 
and eNOS peptides suggesting that the introduction of a negative charge at these sites weakly disrupt 
the electrostatic interactions that stabilize CaM binding to the canonical nNOS and eNOS CaM-
binding domain and implying that phosphorylation at these sites inhibit NOS activity. These results 
are in agreement with past phosphorylation studies (Greif et al., 2004; Mishra et al., 2010; Piazza et 
al., 2012; Spratt et al., 2008). Taking a look at the kon : koff ratios, we observed ratio values for nNOS 
peptide of 0.73, 1.29, 0.57, 1.23 and 2.65 for phosphomimetic mutants T79D, S81D, T79D/S81D, 
S101D and Y99E, respectively. For eNOS peptide binding, we observed ratios of 0.72, 0.77, 0.47, 
0.54 and 0.41 for the same phosphomimetic mutants. These ratio values did not match our expected 
results where lesser relative affinity should correlate to ratio values of >1, suggesting that the 
dissociation of the NOS-CaM complex is favored due to higher dissociation rates compared to the 
rate of association. These interactions are further examined in Section 2.4.3.  
Comparing the binding results with the activity profiles determined by Spratt et al. (2008), 
the diminished amount of binding correlated well with diminished activity observed for CaM central 
linker phosphomimetic proteins T79D, S81D, T79D/S81D as well as the phosphomimetic mutant 
S101D (Figure 2.12). As previously mentioned, the phosphorylation of Y99 was observed to induce 
hypoxia in newborn piglets due to increased nNOS activity (Mishra et al., 2010). Although our 
binding study shows that there is overall, lesser relative affinity for our phosphomimetic Y99E 
compared to wildtype for both peptides, we do observe a corresponding large increase in the rate of 
association in binding the nNOS peptide compared with the eNOS peptide. This discrepancy is most 
likely the reason for the induction of detrimental effects observed in piglets. The relationship between 
cNOS peptide binding and cNOS activation for phosphomimetic mutants are further examined in 
Section 2.4.3. 
 
2.3.4 L-SPR Binding Kinetic Analysis of CaM Mutant Proteins with iNOS Peptide 
Unlike the cNOS peptides, the immobilization of iNOS peptide required the use of a special 
functionalized sensor chip. In contrast with the cysteine modified cNOS peptides, the iNOS peptide 
contained a cysteine in the middle of the sequence (Table 2.2). Although it would have been 
beneficial to use the inherent traits of the peptide for immobilization to reduce the amount of 
modifications needed, one of the disadvantages of using immobilization techniques is ensuring proper 
orientation of the ligand on the surface (O’Shannessy & Winzor, 1996). With the cysteine in the 
middle, the orientation of the peptide could not be controlled. A non-uniform surface could lead to 
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errors in readings and misinterpretation of results (O’Shannessy & Winzor, 1996). Therefore, the 
strong streptavidin-biotin bond was employed.  
Streptavidin is a 52.8 kDa protein that has an extremely high affinity for biotin, a water-soluble 
B-vitamin. Streptavidin’s affinity for biotin has a reported KD on the order of 10
-14 mol/L, making this 
bond one of the strongest non-covalent interactions known in nature. This interaction is heavily used 
in molecular biology and biotechnology due to the streptavidin-biotin complex being resistant to a 
multitude of organic solvents, denaturants, detergents, proteolytic enzymes, and extreme temperatures 
and pH.  Only extremely harsh conditions are able to break this interaction, which can oftentimes 
denature the protein analyte being studied.  
With this in mind, the iNOS peptide was synthesized with a biotin label at the N-terminus 
(Table 2.2) and a gold sensor chip functionalized with streptavidin was provided by Nicoya 
Lifesciences. Initial immobilization tests using 20 ug/mL of biotinylated iNOS peptide showed strong 
binding to the streptavidin functionalized sensor chip as indicated by an average λ shift of at least 0.7 
nm. Titration of 500 nM wt CaM sample produced a very small response. However, the CaM-iNOS 
peptide complex did not dissociate during the dissociation phase and could not be removed using 
EDTA regeneration solution. iNOS enzymes are known to have a high affinity for CaM. These results 
correlate with previous SPR studies by Zoche et al (1996) and reinforce the fact that the binding of 
CaM to iNOS is Ca2+-independent.  
A harsher method was employed using strong acidic conditions to dissociate wt CaM from the 
iNOS peptide. A solution of 10 mM HCl (pH 2) was used in attempts to dissociate the CaM-iNOS 
peptide complex. Initial tests showed full dissociation of wt CaM. However, the acidic conditions 
were too harsh and disrupted the streptavidin-biotin interaction on the surface, displayed as an 
approximate 60% reduction in the baseline after each subsequent injection of HCL. The incomplete 
reduction of the response back to the original baseline heavily indicated that not all of the 
streptavidin-biotin bonds were broken. Originally thought to be stable over a wide range pH, strong 
evidence from affinity studies revealed that the streptavidin-biotin bond is actually disrupted at acidic 
conditions of ≤ 𝑝𝐻4. Milder regeneration conditions were attempted using 100 uM HCl (pH 4), but it 
was not enough to dissociate CaM from the peptide, indicated by the plateau in the response signal.   
We attempted to solve the approximate 60% loss of peptide on the surface after injection of 
HCl regeneration solution by adapting the method to try and regenerate the ligand surface through 
supplemental injections of iNOS peptide after the regeneration phase. The same initial steps were 
carried out: immobilization of the iNOS peptide, immediately followed by a 50 nM CaM association 
phase, a dissociation phase in running buffer and then a regeneration phase by injection of 10 mM 
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HCl. Unlike the previous experiments, another 20 ug/mL iNOS peptide injection was completed 
before the next [CaM] association. This process was repeated for 150, 450 and 1350 nM CaM 
samples. The response signals for all concentrations of CaM were inconsistent, non-uniform and did 
not follow a concentration-dependency like that seen with CaM and cNOS peptides, therefore the data 
was unsuitable for kinetic rate analysis. Furthermore, repeated disruption and regeneration of ligand 
on the surface is not recommended because the quality of ligand binding and the uniformity of the 
surface cannot be confidently ascertained. A non-uniform surface could lead to misinterpretation of 
the results and false binding interaction analysis (O’Shannessy & Winzor, 1996).  
Due to the harsh acidic requirements needed to dissociate the NOS-CaM complex and the 
disruption of the streptavidin-biotin interaction under those conditions, a new regeneration solution 
was tested. Urea, a chaotropic denaturant, was used. Urea is known for its ability to denature several 
proteins such as CaM, by destabilizing internal, non-covalent bonds between atoms, but is not known 
to disrupt the streptavidin-biotin complex. The original method was employed with the variation of 
using 1M Urea as the regeneration solution3. This test showed that the urea did not affect the 
streptavidin-biotin interaction but no dissociation of CaM and iNOS peptide was observed.  
Overall, we were not able to find a method that can regenerate the surface with full dissociation 
of the CaM-iNOS peptide interaction without disrupting the streptavidin-biotin complex. We hope to 
explore other techniques and strategies to accomplish our goal of monitoring CaM protein binding 
with the iNOS peptide.  
2.4 Discussion  
The goal of this chapter was to increase our understanding of the NOS-CaM interactions by 
investigating the binding interactions of CaM mutants and CaM constructs to peptides corresponding 
to the canonical CaM-binding domains of all 3 NOS isozymes through the determination of the 
binding kinetics. Using SPR, an optical bioanalytical method used to measure bimolecular 
interactions, we could determine the parameters we set out in our goal. These binding parameters 
would be used to compare with past activity profile studies using the same CaM mutants to activate 
full NOS enzymes. We set out to determine if there is a relationship between elements and structures 
of CaM binding and their ability to activate NOS catalysis.  
The binding kinetics were derived with the use of an L-SPR platform. NOS peptides were 
immobilized onto a surface and the different CaM proteins were allowed to bind in a concentration 
                                                      
3 The system was washed with injections of running buffer several times to remove any 
traces of urea before any other analyte samples were added.  
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dependent manner. This is the first time SPR kinetic parameters have been determined for EF-hand 
pairs, TnC chimeras and phosphomimetic CaM mutants. Initial SPR analysis using traditional 
techniques was previously done on wt CaM binding with nNOS and iNOS peptides (Zoche et al., 
1996). Comparison of our binding parameters with those from Zoche et al (1996) show that the values 
derived from traditional SPR vs. L-SPR are comparable. The discrepancies can be attributed to the 
longer EM-field-decay length of metal films in traditional SPR sensors vs. the shorter EM-field-decay 
length within nanoparticles in L-SPRs. The decrease of the metal surface height from the use of 
nanoparticles compared to continuous metal film is also known to increase the overall response of the 
sensogram (Yonzon et al., 2004).  
Past studies have shown that the binding of CaM plays a key role in the activation of electron 
transport within cNOS enzymes, however its role in activation of iNOS is not well understood 
(Campbell et al., 2014). This is attributed to the Ca2+-independent nature of iNOS with respect to 
CaM binding. With this in mind, it is extremely unfortunate that the binding kinetics could not be 
observed for any of the CaM proteins with iNOS peptide due to the inability to fully dissociate the 
iNOS peptide/CaM complex without disrupting the sensor surface. This set of data would have been 
very insightful in understanding more of the NOS-CaM interaction.  
As demonstrated in the results section (Section 2.3), the use of mutant CaM proteins displayed 
varying binding profiles for both cNOS peptides within each set of mutants and demonstrated that by 
changing different elements of CaM affect different elements of its interaction with NOS enzymes. 
These specific interactions are further explained in the following subsections below.   
 
2.4.1.1 Analyzing the Binding Interactions Between CaM-TnC Mutants and cNOS 
Peptides 
Using the TnC mutants, we were able to observe the importance of each specific EF-hand domain in 
cNOS binding and activation by effectively changing the functionality of individual EF-hands while 
retaining structure (Su et al., 1995). With respect to TnC protein activation of nNOS enzyme, only the 
2TnC construct was able to fully activate overall NOS activity in terms of •NO production, 
cytochrome c reduction and NADPH oxidation (Figure 2.10). Exchanging EF-hands domain 1,3 and 
4 greatly reduced nNOS activity in all areas with the exception of 3TnC and 4Tnc mutants retaining 
substantial ability to transfer electrons from NADPH into the reductase domain as observed in their 
cytochrome c reduction activity comparable to wt CaM. Our binding data shows that all CaM-TnC 
mutants are able to associate and bind the NOS-CaM binding domain with reduced affinity compared 
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to wt CaM, with the exception of 4TnC, where replacing EF-hand 4 in CaM with the same domain 
from TnC stabilizes its overall binding interaction to the nNOS peptide. Changes to EF-hands 2, 3 
and 4 show an increase in the rate of dissociation of the NOS-CaM complex (high relative koff). This 
corroborates the idea from Newman et al. (2004) in that CaM-1TnC, CaM-3TnC and CaM-4TnC may 
make important contacts with sequence regions outside the nNOS CaM-binding domain that are 
important for nNOS activity and that elements within CaM EF-hand 2 aren’t as important for nNOS 
activity. Furthermore, this explains how the observed increased affinity for CaM-4TnC for the CaM 
binding domain is not indicative of its ability to activate the full nNOS enzyme as we are only 
looking at specific binding of CaM proteins in terms of the CaM-binding domain. 
With respect to TnC mutants binding to eNOS peptide, we see that replacing elements with the 
N-terminal domain of CaM with elements from TnC (TnC and 2TnC) increases its affinity for the 
eNOS CaM-binding domain, where the NOS-CaM complex is quite stable as seen by slow 
dissociation rate (high relative koff) and low kon : koff  ratio. This suggest that elements within the N-
terminal domain of CaM aren’t as important for eNOS peptide binding. On the other hand, replacing 
EF-hands within the C-terminal domain of CaM (3TnC and 4TnC) greatly diminishes the affinity of 
CaM proteins for the eNOS peptide (Figure 2.10). We can see that by removing these elements, the 
interaction is destabilized as seen with the great increase in dissociation of the NOS-CaM complex 
(low relative koff). These results suggest that elements within the C-terminal domain of CaM are 
crucial for eNOS binding. CaM is believed to bind the NOS CaM-binding domain in an antiparallel 
fashion where elements within CaM-4TnC are closest to the oxygenase domain of NOS enzymes 
(Aoyagi, 2003). These results are consistent with a recent solution-state structural study of wt CaM 
binding to the eNOS peptide where they demonstrated this antiparallel binding and showed that the 
N-terminal domain of the NOS-CaM complex is more rigid and less dynamic than the C-terminal 
domain (Piazza et al., 2016). By replacing elements within the C-terminal domain of CaM, such as 
using 3TnC and 4TnC constructs, the important anchoring contacts and interactions CaM makes with 
the CaM-binding domain are disrupted, causing a decrease in binding affinity as seen in Figure 2.10 
with regards to decreased relative binding in terms of affinity. 
With respect to eNOS activation, TnC constructs showed a similar activation profile as 
previously seen with nNOS but the CaM mutations had less effect on the transfer of electrons within 
the reductase domain as demonstrated by the decrease in •NO production and increase in cytochrome 
c reduction and NADPH oxidation, similar to that seen with nNOS activation. By changing elements 
that help CaM anchor to the NOS CaM-binding domain, CaM is weakly bound to the peptide, 
lowering the rate of effective FMN to heme electron transfer and increasing the rate of cytochrome c 
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reduction. Similar to TnC binding and activation of nNOS, the amount of relative binding of TnC 
mutants to eNOS is not indicative of its ability to promote overall activation.  
2.4.1.2 Analyzing the Binding Interactions Between CaM EF-Hand Pair Mutants and 
cNOS Peptides 
Similar to the CaM TnC mutants, the EF-hand pair mutants look at the importance of EF-hand pairs 
but within their associated globular domains. Taking a look at the single EF-hand pairs, we were not 
able to determine appropriate binding kinetics of nCaM and cCaM to immobilized nNOS and eNOS 
peptides as the binding kinetics on the SPR resembled bulk shift effects. These results correlate well 
in that the single EF-hand pairs were not able to activate any substantial NOS activity with the 
exception of nCaM displaying 37% relative cytochrome c reduction activity in nNOS and 17% in 
eNOS enzymes. These results could suggest that the OpenSPR™ platform was not sensitive enough 
to distinguish minor binding interactions of the single EF-hand pairs but were otherwise detected in 
the activity assays. Furthermore, these results prove that both globular domains of CaM are important 
for CaM binding and activation (Spratt et al., 2006). 
On the other hand, binding kinetics were observed for duplicate EF-hand pairs, CaMNN and 
CaMCC. CaMNN displayed greater relative binding for the nNOS peptide and comparable binding to 
wt CaM for the eNOS peptide. The kon: koff ratio of CaMNN was 2.4 for nNOS peptide and 3.2 for the 
eNOS peptide. Even though the CaMNN construct dissociates faster from the NOS-CaM complex 
compared to wt CaM, it is offset by its fast association for both cNOS peptides, thereby displaying 
high affinity. CaM CC displayed the opposite trend where it displayed significant greater binding for 
the eNOS peptide, with 2x greater affinity than wt CaM, and comparable binding to wt CaM for the 
nNOS peptide. With CaMCC, a kon: koff ratio of <1 is observed, signifying that elements of the CaM 
C-terminal domain stabilizes the NOS-CaM complex with its slow dissociation rate (high relative 
koff). These results again corroborate the importance of elements within the  CaM C-terminal domain 
and how these elements are crucial in CaM binding, especially in terms of eNOS binding (Piazza et 
al., 2016). These results reflect the trend we observed when we investigated the binding and 
activation of CaM 3TnC and 4TnC constructs, which exchanged CaM C-terminal EF-hand domains 
with those from TnC.  
Taking a look at EF-hand pair activation of NOS activity, CaMNN was the only construct that 
showed substantial •NO production in both cNOS enzymes. Elements within the N-terminal region of 
CaM are most likely important in activating •NO production by facilitating the conformational 
change of NOS into the output state from the input state and thus improving efficiency of electron 
transfer from the FMN into the catalytic heme domain (Melody G Campbell et al., 2014; Spratt et al., 
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2006). The N-terminal elements of CaM bind closer to the C-terminal domain of NOS and therefore 
these elements are most likely important in making important contacts with FMN that are needed for 
the activation of the conformational change (Aoyagi, 2003). In terms of electron transfer within the 
reductase domain of nNOS to cytochrome c, Newman et al (2004) previously stated that the CaM 
requirements for promotion of FMN domain release in eNOS are not as stringent as it is in nNOS as 
CaMCC was able to activate minor eNOS activity without having elements of the N-terminal domain. 
Our binding data shows that the CaMCC construct binds 2x as strong to the eNOS peptide than wt 
CaM, corroborating the suggestion by Spratt et al. (2006) that duplicate EF-hand pairs can in fact 
occupy the entire CaM-binding site, where the binding of one C-terminal domain of CaMCC can 
stabilize the interaction of the 2nd C-terminal domain with the N-terminal recognition site. These 
protein constructs were used to observe how the 2 globular domains within CaM affect NOS binding 
and activation. Overall, out of the 3 sets of mutants we investigated, the EF-hand mutants displayed 
the highest correlation of their binding profiles with their ability to activate NOS enzymes.  
2.4.1.3 Analyzing the Binding Interactions Between Phosphomimetic CaM Mutants 
and cNOS Peptides 
Unlike the CaM TnC and EF-Hand Pair mutants, CaM phosphomimetic mutants were studied to 
investigate natural in vivo regulations of CaM and how they affect NOS activation and binding. Due 
to the difficulty in individually phosphorylating single amino acids, single point mutations of known 
post-modified amino acids into glutamate and aspartate were done to mimic phosphorylation at the 
specified sites (Spratt et al., 2008).  
In terms of central linker phosphomimetic mutants T79D, S81D and T79D/S81D nNOS 
peptide binding, we see that all 3 mutants showed less affinity for the peptide compared to wt CaM. 
Taking a closer look at the kon : koff ratios, we see varying ratios between the mutants (0.79, 1.29, 0.57 
for respectively). There is no clear relationship on how the ratio explains the amount of relative 
affinity. In terms of eNOS peptide binding, we see a similar trend where all 3 mutants displayed 
lower affinity compared to wt CaM and relatively lower affinity compared to nNOS peptide binding. 
Looking at kon : koff ratios, we get a different trend where all ratios are <1 (0.72, 0.77 and 0.47, 
respectively). This does not correlate with our expected trend where having a slower dissociation rate 
(higher relative koff) signifies a more stable affinity. Comparing the nNOS activities, we see that 
central linker phosphomimetic mutants displayed relatively similar rates of NADPH oxidation, 
increased rates of cytochrome c reduction but an overall decrease in •NO production compared to that 
of wt CaM. In contrast, for eNOS activation we see slightly higher relative activities of NADPH 
oxidation and •NO production with a decrease in electron transfer activity to cytochrome c from the 
 
 55 
reductase domain. These results do not agree with Grief et al. (2004) where they demonstrate that 
phosphorylation of CaM proteins should attenuate overall eNOS activation. Therefore, our binding 
study does not correlate well with the activity study completed by Spratt et al. (2008).  
With respect to S101D peptide binding, we see decreased affinity for both cNOS peptides. 
Similar to the CaM central linker phosphomimetic mutants, there is no observed trend by looking at 
the kon : koff ratio. Phosphorylation of S101 was previously reported to decrease eNOS activity (Greif 
et al., 2004). S101 is located in the loop region of EF-hand 3, which is located in the C-terminal 
domain of CaM. Like we saw with previous CaM mutants, changing interactions within the C-
terminal domain decrease its level of binding to NOS. Our observed decrease in relative affinity of 
S101D mutant to cNOS peptides correlates with the previously observed decrease in not only eNOS 
activation (Spratt et al., 2008), but possibly with nNOS activation as well.  
Lastly, with respect to Y99E, we see that the substitution of Y99 with a glutamic acid residue 
decreases the affinity of CaM for both nNOS and eNOS peptide. Structural studies have shown that 
the introduction of a negative charge at Y99 perturbs the binding interactions of CaM EF-hand and 
EF-hand 4 (Piazza et al., 2012). Once again, we see how crucial certain elements within the C-
terminal domain of CaM are in terms of NOS binding and by changing these elements, we can greatly 
affect CaM affinity. Furthermore, it was previously reported that phosphorylation at this site induces 
hypoxia in newborn piglets due to increased nNOS activity. The activity study completed by Spratt et 
al. (2008) demonstrate a slight increase in nNOS activity for all 3 NOS assays and a decrease in both 
NADPH and overall •NO production in eNOS (Piazza et al., 2012). The slight increase in overall 
nNOS activity could be attributed to the increase in kon.  
 
Overall, using SPR, we determined the binding kinetics of CaM mutants to peptides for the 
canonical CaM-binding domains of NOS enzymes. With comparison of previously determined 
activity profiles for the same exact mutants, we saw varying results of how the different elements and 
structures of CaM affect activity. Notably, we saw a recurring trend where changing elements of the 
EF-hand domain found in the C-terminal of CaM greatly affected its level of binding to NOS 
peptides. Furthermore, we saw many variances in the amount of CaM binding affinity for NOS 
peptides compared to CaM activation of NOS enzymes. Once again, a caveat to this particular study 
is that we are specifically only looking at the binding interactions between CaM proteins and the 
canonical CaM-binding domain. This implies that the local binding interactions between CaM and the 
CaM binding domain do not sufficiently justify the mechanisms involved in the binding and 
activation of full NOS holoenzymes. We observed this frequently across all 3 CaM mutant constructs, 
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where elements of CaM that were not involved in forming the binding complex with the NOS peptide 
were in fact important in full activation of the enzyme. This correlates with findings from Venema et 
al, (1996) and Ishida and Vogel (2006). NOS is an extremely dynamic protein, and different elements 
of CaM that may not be involved in the NOS-CaM binding complex may interact with different 
segments of NOS that can either promote or inhibit activation of the enzyme. Despite this fact, it is 
still important to quantify the level of interaction of CaM proteins with the CaM-binding domain to 





Development of a Nitric Oxide Synthase Electrochemical Biosensor 
 
3.1 Introduction  
The study of NOS enzymes is important because they are integral proteins in human physiology. Due 
to their physiological relevance (Section 1.2.2), the pharmaceutical industry has a keen interest on 
finding NOS isoform-specific inhibitors. Coupled with the limited assay methods used currently to 
measure NOS activity, there is significant interests in developing a new bioelectronic system that can 
efficiently and accurately analyze NOS enzyme catalysis. Converting biological events, such as NOS 
catalysis, to an easily detectable and processed electrical signal can be a difficult process due to the 
intricacies of connecting an electronic device into a biological environment (Grieshaber et al., 2008). 
However, with recent advances over the past 2 decades in the fields of biosensing and 
bioelectrochemistry, electrochemical biosensors can now be confidently utilized to monitor 
electroactive proteins (Mehrotra, 2016). Developing a new technological platform with efficient, 
rapid and less expensive NOS activity detection would exponentially increase our understanding on 
the full mechanism of NOS by improving our ability to measure its activity. Furthermore, this 
technology could also speed up and simplify the drug development process needed in the 
pharmaceutical industry by expediting the screening process (Castrignanò et al., 2014), increasing the 
potential for new therapeutic compounds to be discovered that could be used to treat abnormal 
physiological NOS activity.  
 
3.1.1 Electrochemical Biosensors  
Electrochemical biosensors are analytical devices that can convert biological responses into a 
measurable electrical signal (Grieshaber et al., 2008; Thévenot et al., 2001). Remarkably, biosensor-
related research has had exponential growth over the past few decades. The development of 
biosensors was pioneered by Clark and Lyons in the 1960’s and their contributions has led to the 
current day use of various types of biosensing equipment, including enzyme-based, tissue-based and 
DNA-based biosensors as well as immunosensors and thermal and piezoelectric biosensors 
(Mehrotra, 2016). There is great demand for the development of an electrochemical NOS biosensor 
for its clinical relevance and the ability to study the biochemical regulation of NOS enzymes. A 
typical biosensor contains three main components: the bioregulatory element, a signal transducer and 
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lastly, a detector (Figure 3.1) (Thévenot et al., 2001). The main criteria a biosensor must have are 
(Schneider & Clark, 2013):  
1. highly specificity 
2. be independent of physical parameters such as pH, temperature and mechanical turbulence 
3. accurate, precise and reproducible responses over the concentration range of interest; and 
lastly 
4. be cheap, small, portable and easy to use for semi-skilled operators  
3.1.1.1 Enzyme-based Electrochemical Biosensors  
Enzyme-based biosensors are developed based on immobilization methods and bioelectrochemistry. 
With these types of biosensors, electroactive species, mostly redox enzymes, are typically 
immobilized onto an electrode surface using van der Waals forces, ionic bonds and/or covalent 
interactions (Castrignanò et al., 2014; Oku et al., 2004; Schneider & Clark, 2013; Sultana et al., 
2007). Through the coupling of the enzyme with an electrical interface, the enzymatic activity of the 
redox protein can be measured as an electrical response.  
 
Figure 3.1 - Biosensor Component Requirements 
Depicted on the left are 4 widely used bioregulatory elements and possible samples they can be 
attained from. Signal transducers take the biological response of the bioregulatory element and 
convert it into an electrical response that the detector can process. This figure was reprinted from 
Sensors. Switzerland, 8(3) Grieshaber, D.; MacKenzie, R.; Vörös, J.; Reimhult, E. Electrochemical 




3.1.1.2 Electrochemical Detection of Enzyme-Based Biosensors 
Electrochemical biosensors can either measure current (amperometric), potential or charge 
accumulation (potentiometric) or the conductive properties of a medium (conductometric) between 
electrodes. The measurable electrical signal is a result of the oxidation or reduction of the redox 
enzyme undergoing its biochemical reaction (Grieshaber et al., 2008). The majority of enzyme-based 
platforms use amperometric detection, where the current is measured at a constant potential, also 
known as amperometry. An increase in the current upon addition of an electrical potential is 
correlated with the catalytic activity of the redox enzyme against a candidate substrate (Schneider & 
Clark, 2013) . There are many types of amperometric methods, however the most widely used for 
enzyme-based platforms is cyclic voltammetry. Voltammetry is the measure of current as a result of 
varying the potential (Mabbott, 1983). With cyclic voltammetry, the voltage is swept between two 
fixed potentials at a fixed rate. When the voltage reaches one of the fixed potentials, the scan is 
reversed and the voltage is swept back to the original potential. It is a popular technique due to its 
usefulness in obtaining information about the redox potential and the chemical rate constant of 
analyte solutions(Grieshaber et al., 2008; Mabbott, 1983).  
Additionally, since enzymes are immobilized onto electrodes, reactions occur in close 
proximity to the electrode surface. Therefore, the electrodes themselves play an important role in the 
performance of electrochemical detection. Based on the chosen function of a specific electrode, the 
electrode material, its dimensions and any surface modification can influence the detection ability of 
the enzyme (Mehrotra, 2016). Typically, electrochemical sensing requires a reference electrode, a 
counter or auxillary electrode and a working electrode. The enzyme is immobilized on the working 
electrode, which acts as the transducing element for the biochemical reaction. On the other hand, the 
counter electrode establishes a connection to the electrolytic solution so that a current can be applied 
to the working electrode. Lastly, the reference electrode, usually Ag/Ag/Cl, is kept away from the 
reaction site on the working electrode to maintain a known and stable potential. Electrodes are made 
of conductive and chemically stable materials, which are usually platinum, gold, carbon and silicon 
depending on the analyte being studied(Grieshaber et al., 2008) .  
 
3.1.1.3 Cytochrome P450-Based Biosensors 
To date, the most utilized and extensively researched redox enzymes for bioelectrochemistry 
applications are the family of cytochrome P450 (CYP or P450) enzymes, along with their redox 
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partners, the family of cytochrome P450 oxidoreductase (CYPOR) enzymes. CYP proteins are a 
family of heme-containing enzymes associated with the metabolism of xenobiotics and other 
endogenous chemicals within humans (Castrignanò et al., 2014) NOS enzymes share similarities with 
P450 enzymes in that they are also heme containing proteins found in almost all types of tissues. Both 
NOS and CYPs conduct electron transfer through flavin cofactors, with the difference of P450 
enzymes being coupled with CYPOR enzymes, which are quite similar to the reductase domain of 
NOS enzymes and provide the reducing equivalents for heme catalysis (Schneider & Clark, 2013).  
In the last ten years, there have been several reports of successful direct bioelectrochemical 
platforms using P450 enzymes adsorbed onto electrode surfaces to screen against drug candidates 
(Joseph et al., 2003). Past studies have designed novel CYP biosensors and have reported comparable 
kinetics to literature values and even having the ability to perform inhibitor studies (Newman et al., 
2004). CYP biosensors have been used extensively in the pharmaceutical industry where lead 
compounds in drug development are screened against immobilized CYP enzymes as they are 
responsible for most of the drug metabolism within our bodies. Knowing the CYP profile of a drug 
allows principle investigators to predict possible harmful interactions that are caused by the inhibition 
or induction of a specific CYP isozyme(Joseph et al., 2003; Schneider & Clark, 2013).  
Conversely, recent studies done have shown supporting evidence that immobilizing P450 
enzymes directly onto electrodes can induce a conformational change of P450 enzymes into inactive 
cytochrome P420s by a process known as electrical fouling (Schneider & Clark, 2013). P450 enzyme 
species are characterized by absorption of the reduced heme at 420 nm, signifying a loss of the 
proximal cysteine ligand. Through analysis of the electrode surfaces after catalysis, the unstructured 
orientation of CYP enzymes during the immobilization step is has been found to be a major 
contributing factor to protein denaturation (Schneider & Clark, 2013).  
 
3.1.1.4 Electrochemical Biosensor Advantages and Disadvantages 
Overall, electrochemical biosensors are extremely useful tools because they can obtain intrinsic 
thermodynamic and kinetic properties of many protein-protein complexes. Furthermore, biosensor 
experiments are high throughput methods that can be developed for high specificity of virtually 
almost any substrate, even allowing the use of turbid samples such as whole cell extracts. They are 
highly repeatable, robust and faster than any conventional assay method used today. Lastly, other 
advantages come in the form of their miniaturization, excellent detection limits and small analyte 
volumes (Mehrotra, 2016; Shruthi et al., 2014).  
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Although there are many benefits, there are a few disadvantages, especially in regards to 
enzyme based-platforms. First, to develop these platforms can be expensive due to the source, 
extraction, isolation and purification of large amounts of active enzyme. Second, the adsorption of the 
purified enzyme onto the electrode surface is essentially irreversible. Harsh conditions are needed to 
reverse the immobilization process. Additionally, there can be potential issues with the deactivation 
of enzymes after a relatively short period of time, unless stored under proper conditions (Shruthi et 
al., 2014). Therefore, there is a limited shelf life for these applications. Last but not least, the viability 
of the biosensor is dependent on the ability of the bound enzyme to conduct redox reactions. The loss 
of activity can occur through the denaturation of the ligand by electrode fouling as seen in CYP 
biosensor examples (Schneider & Clark, 2013).  
 
3.1.2 Developing a Nitric Oxide Synthase Electrochemical Biosensor 
To reemphasise, there is high demand for the development of a NOS electrochemical biosensor for its 
clinical relevance and the need to still characterize NOS mechanisms. NOS enzymes are redox active 
proteins; therefore, they are highly suitable to be adapted for bioelectrochemical sensing platforms. 
Past experiments showing the viability of CYP biosensors shows the potential to adapt and develop a 
new NOS biosensor. The main objective of this chapter is to develop a new NOS-based 
electrochemical biosensor with the purpose of being able to measure NOS catalytic activity.  
 
3.1.2.1 Initial Design Approach  
Using the examples of previous CYP biosensors for inspiration, we attempted to design a new NOS 
sensing platform. The studies we conducted in Chapter 2 showed that we could immobilize NOS 
peptides (the biorecognition element) on a gold nanoparticle surface using the thiol-gold interaction, 
and observe CaM analyte binding (target molecule). Essentially, with our SPR method, we developed 
an optical CaM affinity biosensor where we could detect the specific binding of analyte CaM proteins 
to an immobilized biorecognition element. With proof that we could immobilize a NOS structure on a 
gold surface, we decided to immobilize NOS enzymes onto a gold electrode.  
However, knowing about denaturation of electrode immobilized proteins as seen in the 
examples of CYP sensors, a prospective solution for a NOS sensor can be achieved by using a CaM 
protein tether (Figure 3.3). With this concept, instead of directly immobilizing the NOS enzyme 
directly on the surface, we could immobilize CaM, a stable protein that displays strong binding 
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affinity for NOS and is necessary for electron transfer within the enzyme (Section 1.4.1). Using this 
pseudo-sandwich format, CaM will act as the initial biorecognition element that will target NOS 
enzymes close to the surface of the electrode, NOS will be used as a secondary biorecognition 
element that will act as our electroactive catalyst. Utilizing the same thiol-gold chemistry that was 
used to bind NOS peptides to a gold nanoparticle surface (Section 2.3.2), CaM would be similarly 
modified with a cysteine group at one end of the protein. Due to known antiparallel binding of CaM 
to NOS enzymes (Aoyagi, 2003), 2 cysteine-modified CaM constructs were developed, yielding 
Nterm-Cys CaM and Cterm-Cys CaM constructs (Invitrogen, Life Technologies) (Figure 3.3). 
Testing both constructs could ensure proper binding orientation of NOS enzymes on the surface.  
 
Figure 3.2 - Indirect-direct immobilization of NOS enzymes using a CaM protein tether  
CaM will be immobilized on a gold surface using Cysteine-modified ends. Introduction of NOS 
enzyme will result in protein binding, indirectly immobilizing NOS to the surface. 
Before applying our model onto a gold electrode platform, testing the viability of our constructs on a 
gold surface would be beneficial. L-SPR will be used to determine the optimal conditions for the 
immobilization of the protein tether. Furthermore, the affinity of the second recognition element, the 
NOS enzyme, will be determined using L-SPR analysis. Once we have optimized our binding 
methods, we hope to translate from an optical platform onto an electrical platform.  
 
 
3.2 Experimental Procedures 
 
3.2.1 Expression and Purification of Cysteine-modified C-terminal and N-terminal CaM 
Synthesized human cysteine-modified C-terminal & N terminal CaM proteins were expressed in 
BL21 (DE3) E.coli cells transformed with pHuCaMCtermCys and pHuCaMNtermCys plasmids 
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(Invitrogen, Life Technologies) (Appendix A), as previously described for wild-type CaM (section 
2.1.1).  
Synthesized human cysteine-modified C-terminal & N terminal CaM proteins were purified as 
previously described for wild-type CaM (section 2.1.2).  
 
3.2.2 Characterization of CaM and Cysteine-modified Terminal CaM 
Both cysteine modified CaM proteins were characterized as previously described for wild-type CaM 
(Section 2.2.6) 
 
3.2.3 NOS Enzymes 
Purified bovine eNOS and human nNOSoxyFMN enzymes were a generous gift from Danica 
Estavillo and Dr. Mike Piazza (Guillemette Lab)  
 
3.2.4 SPR Gold Chip Preparation  
The interactions of all proteins used in this chapter were completed using a standard gold sensor chip. 
The gold sensor chip was prepared as previously described in Section 2.2.7.1.  
 
3.2.5 SPR Protein Binding Kinetic Analysis of eNOS Holoenzyme and Immobilized 
Cysteine-modified Terminal CaM 
 
The gold chip and Open SPR was prepared as previously described in Section 2.2.7, up until the 
equilibration of a new chip. The surface of the gold chip was primed with a 200 uL injection of a 
solution consisting of 6.25:1 cysteamine to cysteine modified-terminal CaM in PBS equilibration 
buffer. Several 200 uL injections of 1 mM cysteamine in PBS buffer were completed to saturate the 
rest of the surface and prevent NSB. After each injection, the equilibration buffer was pumped for at 
least 10 minutes or until the signal was stabilized.  The buffer was switched to PBS analyte buffer as 
mentioned in Section 2.2.7.3. A range of NOS holoenzyme concentrations (500 nM, 300 nM, 200 
nM, 150 nM, 100 nM, 50 nM) were prepared in PBS analyte buffer to inject into the OpenSPR 
individually and allowed to equilibrate. An injection of PBS regeneration buffer was done to 




3.2.6 Reduction of Non-Specific Binding of NOS enzymes on the SPR 
Preliminary experiments from Section 3.2.5 showed that strong non-specific binding occurs between 
NOS enzymes and the gold chip surface. Different running conditions and additives were tested to 
optimize the best running conditions for the binding of NOS enzymes to immobilized CaM and 
reduce and eliminate NSB. These methods include the use of surface blockers as well as protein and 
chemical additives and are described in the following sections below. 
 
3.2.6.1 Reducing SPR Non-Specific Binding Through Surface Blockers 
The gold chip and Open SPR was prepared as previously described in Section 2.2.7 and 2.2.8, up 
until the equilibration of a new chip on the OpenSPR. Three different surface blockers were tested: 
cysteamine, a neutral SPR-functional polyethylene glycol compound (PEG) (SH-PEG3000-OMe) & a 
basic SPR-functional PEG compound (SH-PEG3000-NH2) PEG compounds were a generous gift from 
the Dieckmann lab. Each compound was tested separately on newly prepared chips. The same 
equilibration, analyte and regeneration buffers were used as previously described in Section 2.2.8. 
The surface of the gold chip was primed with several 200 uL injections of the blocker being 
tested, prepared in PBS equilibration buffer, until no significant change in overall response on the 
sensogram was achieved, showing saturation of the gold surface. DTT was added into all PEG3000 
injections to ensure the PEG was fully reduced. The buffer was swapped into PBS analyte buffer as 
described in Section 2.2.8. A 200 uL injection of 500 nM NOS holoenzyme in analyte buffer was 
done and allowed to equilibrate, followed with a 200 uL injection of PBS regeneration buffer to 
regenerate the surface.  
 
3.2.6.2 Reducing SPR Non-Specific Binding Through Additives 
The gold chip and Open SPR was prepared as previously described in Section 2.2.7 and 2.2.8, 
up until the equilibration of a new chip on the OpenSPR. The addition of bovine serum albumin 
(BSA) as a blocking protein as well as the use of the surfactant Tween 20 to reduce NSB were 
investigated. The same equilibration, analyte and regeneration buffers were used as previously 
described in Section 2.2.8 with the addition of 1% w/v BSA and 0.05% v/v Tween 20 into the analyte 
and regeneration buffers.  
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The surface of the gold chip was primed with several 200 μL injections of the cysteamine 
blocker prepared in equilibration buffer, until no significant change in overall response on the 
sensogram was achieved, showing saturation of the gold surface. The buffer was switched to the 
modified PBS analyte buffer. A 200 μL injection of 500 nM NOS holoenzyme in modified analyte 
buffer was done and allowed to equilibrate, followed with a 200 μL injection of modified 





3.3 Results and Discussion  
 
3.3.1 Protein Expression, Purification and Characterization  
Both cysteine-modified C-term CaM and cysteine-modified N-term CaM were expressed and 
purified. The purified CaM proteins were analyzed by SDS-PAGE and were judged to be over 95%   
 
Figure 3.3 - SDS-PAGE of Cysteine-modified terminal CaM Proteins 
The purified cysteine-modified CaM were run on a 15% SDS-polyacrylamide gel. 10 ug of each 
protein was loaded into an SDS buffer containing 5% BME. Lane 1: Low molecular mass protein 
standard (Bioshop); Lane 2: wt CaM; Lane 3: Cys-Modified Cterminal CaM ; Lane 4: Cys-Modified 
Nterminal CaM 
 
CaM proteins were further verified using ESI-MS to rule out any modifications (Table 3.1). All CaM 
proteins were verified to be the correct size. UV-spectroscopy was used to calculate CaM protein as 
well as verify their identity through characteristic peaks.  










Table 3-1 - UV-Spectroscopy and ESI-Mass Spectrometry Analysis of CaM proteins and NOS 
CaM Protein 
Mass (kDa) (a) 
Concentration (uM) Theoretical 
(b)  Observed 
    
wt CaM 16.706 16.705 232 μM 
Cterm Cys CaM 21.374 21.371 710 μM 
Nterm Cys CaM 23.460 23.464 432 μM 
(a) – Masses of deconvoluted ESI-MS spectra are accurate to within 4-5 Da.  
(b) – Calculated mass based on amino acid sequence 
 
3.3.2 SPR Protein Binding Kinetic Analysis of NOS Holoenzyme and Immobilized 
Cysteine Modified Terminal CaM 
We verified that the cysteine-modified CaM protein could bind to the cNOS peptides with 
comparable kinetics to wt CaM proteins (results not shown). Strong immobilization of the of C-
terminal cysteine-modified CaM onto the surface was achieved using a 6.25:1 ratio of cysteamine 
surface blocker and CaM protein (Figure 3.4.A). More injections of cysteamine were added to 
saturate the surface (Figure 3.4.B). We tested to see if a binding response would be detectable for the 
addition of eNOS peptide. Upon addition of peptide, a slight increase in signal was observed, 
bringing the baseline slightly higher (Figure 3.4.C). This indicated the binding of the peptide to the 
immobilized CaM. The small response is most likely due to the large difference in size between the 
ligand and the analyte in question. Addition of EDTA did not bring the signal down (Figure 2.4.D), 
indicating no dissociation of the CaM-eNOS complex. To test if this complex was formed, we added 
an injection of eNOS holoenzyme. eNOS enzyme should not be able to bind if the CaM-eNOS 
peptide complex was formed.  
Upon injection of 200 nM eNOS holoenzyme, a strong binding response was observed (Figure 
3.4.E). We tested to see if the interaction was specific. With addition of EDTA regeneration solution, 
the complex could not be dissociated (Figure 3.4.F). The sensogram showed no decrease in signal, 
showing only a bulk shift response. Subsequent additions of enzyme showed strong binding for each 
injection but with a decrease in wavelength response. This indicated that the addition of eNOS 


















Figure 3.4 - Initial binding tests for Cys-modified C-terminal CaM 
(A) Strong binding of C-terminal Cysteine Modified CaM. (B) Injection of cysteamine to block any 
remaining unbound surface. (C) injection of eNOS peptide displays a binding signal (D) EDTA 
injection does not dissociate the peptide from immobilized CaM (E) strong binding of eNOS 
holoenzyme even with bound peptide indicating non-specific binding (F) EDTA regeneration does 
not remove the enzyme from the surface.  
 
Our initial test indicated that the interaction of the NOS enzymes were non-specific. To test this 
interaction, we injected eNOS holoenzyme in the absence of the Cys-modified CaM onto gold sensor 
chip. A strong binding response was observed, verifying the presence of NSB.  
Non-specific binding is caused by the molecular forces, such as charge and hydrophobic 
interactions, between the analyte and the sensor surface. The non-specific binding of NOS enzyme 
onto the gold surface is most likely due to charge hydrophobic interactions.  
We conducted a series of NSB tests to see if we could increase the specificity of our ligand and 
our enzyme analyte with the use of surface blockers and different buffer conditions.  
 
A 
B C D E F 
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3.3.2.1 Non-Specific Binding tests using Surface Blockers 
The addition of surface blockers will saturate the reactive surface and will attempts to prevent analyte 
binding to the surface. We used cysteamine and different polyethylene glycol (PEG) units.  
Full saturation of the gold surface was achieved by several injections of cysteamine. Saturation 
was judged when the addition of more cysteamine displayed a bulk shift response, indicating that no 
more binding could be achieved. However, upon injection of NOS enzyme, we see a large binding 
response, indicative that the enzyme is unaffected by cysteamine on the surface. NOS is a fairly large 
enzyme and we hypothesize that it can still interact with the gold surface in spite of cysteamine bound 
on the surface.  
To prevent the reach of NOS enzyme to the surface, larger surface blockers were employed. 
Polyethylene glycol (PEG), is a polyether compound that has been used in mnay applications of 
biology. It has a structure that is expressed as H-(O-CH2-CH2)n-OH. We used a 300-unit repeating 
PEG with both a neutral and basic reactive end: 
(1) SH-(O-CH2-CH2)300-OME 
(2) HS-(O-CH2-CH2)300-ONH3 
Similar to the cysteamine blocker, we first blocked the gold surface using 3000-PEG-OMe. 
The PEG was added until a bulk shift response was observed. We added a reducing agent, DTT, to 
ensure the PEG was fully reduced. Upon injection of wt CaM onto the surface, no binding response 
was observed. Upon addition of eNOS enzyme, we saw a similar binding profile seen with previous 
tests. A strong binding interaction is observed indicating NSB of the NOS.  
Lastly, we attempted the use HS-(O-CH2-CH2)300-ONH3 to block the surface. Similar to the 
use of neutral PEG, the amino-PEG was added until a bulk shift response was observed. DTT was 
added to ensure full reduction of the PEG unit. Addition of wt CaM did not induce a binding 
response. Upon addition of eNOS enzyme, we saw a similar binding profile seen with previous tests. 
 
3.3.2.2 Non-Specific Binding tests with Biological and chemical additives 
To further test the reduction of NSB of NOS enzymes on the gold surface, we used a combination of 
biological and chemical additives. Bovine serum albumin (BSA) is a commonly used protein 
blocking agent that prevents non-specific protein-surface interactions. BSA is a globular protein with 
hydrophilic and hydrophobic subgroups. It naturally acts as a carrier protein in blood plasma. It can 
prevent NSB of a protein by encapsulating it, reducing its ability to interact.  
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In addition, chemical additives were employed. Tween 20 is a non-ionic surfactant that may 
disrupt hydrophobic interactions. It is commonly used in biological systems ranging from 0.005% 
v/V to 0.05% v/v and is commonly used in many protein SPR studies.  
We systematically tested different buffer conditions with different combinations of the 
biological and chemical additives. NSB test conditions were done using the following running 
buffers: 
1. PBS, pH 7.5 + 0.1% w/v BSA 
2. PBS, pH 7.5 + 1.0% w/v BSA 
3. PBS, pH 7.5 + 0.05% v/v Tween 20 
4. PBS, pH 7.5 + 1.0% w/v BSA + 0.05% v/v Tween 20  
NOS enzyme was diluted into each running buffer and with each test, the same result occurred, 
a strong binding response of the NOS enzyme.  
A possible explanation for what seems to be happening in regards with NOS enzymes and 
binding interactions on the surface is that the enzyme is too large. Proteins are naturally sticky and 
upon injection of NOS enzyme onto the surface, it sits on top of the surface. Upon attaching to the 
surface, it promotes aggregation of other NOS enzymes to non-specifically bind. This is indicated by 
the binding signals with subsequent injections of NOS enzyme.  There is possible interaction of the 
NOS enzyme with the CaM ligand, however upon binding, it sterically blocks the other immobilized 
CaM proteins with binding. The surface becomes inaccessible and is possibly why addition of EDTA 
regeneration solution cannot dissociate the interaction. 
3.3.3 Summary 
Our goal for this chapter was to develop an electrochemical biosensor with the concept of directly 
immobilizing NOS enzyme onto a gold electrode, which could provide the reducing equivalents to 
activate NOS catalytic activity. Previous studies have implicated that direct immobilization of redox 
enzymes are prone to denaturation due to electrode fouling. We decided to adapt the standard direct 
electrochemistry method and hypothesized that we could circumvent the known fouling of our 
enzyme by immobilizing CaM first onto the surface to act as a protein tether, and use it to indirectly 
immobilize NOS onto the electrode surface, but still close enough for efficient electron transfer.  
We were able to express and purify our CaM protein and we tested the immobilization of our 
construct onto a gold surface with the use of SPR. However, NOS enzymes non-specifically bind onto 
the gold surface, possibly due to its relative size compared to the CaM bound on the surface. We ran 
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systematic tests to remove the non-specific binding, however, we were not yet able to a find a 
solution.  
Overall, the development of new technology for assaying NOS activity is of great importance, 
especially in the field of medicine due to the physiological implications of NOS. Enzyme-based 
electrochemical biosensors and the direct immobilization of NOS enzymes shows a lot of promise for 






4.1 Binding Kinetics for CaM Mutant Proteins Interacting with the iNOS Peptide 
To improve our results, more statistical data must be determined. Binding kinetics will be repeated for 
mutant CaM proteins binding with cNOS peptides. Duplicates were completed for all constructs but 
conducting more trials can help solidify the experimentally determined values for binding kinetics 
and affinities.  
Other methods to observe the binding interactions of mutant CaM proteins with iNOS peptide 
are being explored. A prospective surface being used in sensing technology is gold self-assembled 
monolayers with covalent attachment of the molecule of interest. Another commonly used surface is 
the use of an activated dextran matrix monolayer. Immobilization of a protein can be achieved 
through the covalent attachment of the primary amine. Both surfaces have shown stability in harsh pH 
conditions (Schneider & Clark, 2013) 
Furthermore, it would be useful to validate the binding affinities determined by L-SPR and 
compare them to other binding affinity methods such as ITC. 
 
4.2 Developing a NOS Electrochemical Biosensor  
Our methods to immobilize NOS enzymes onto a gold surface using a CaM protein tether to 
specifically bind NOS enzymes was without success. We are currently exploring different methods to 
help increase the signal to response with the immobilization of CaM and specific interactions with 
NOS enzymes.  
Once we have established the proper running parameters and optimized the binding interaction 
of immobilized CaM and NOS enzymes, we can verify that using a protein tether can be a viable 
immobilization method for direct electrochemistry of NOS enzymes for a new NOS optical biosensor. 
We hope to translate from working under this SPR optical platform and attempt immobilization of our 
protein constructs on a working gold electrode.     
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List of CaM Plasmids Used 
The plasmid constructs used to transfect E.coli for this study are listed here with a description specifying 
the protein sequence and the vector the sequence was contained in 
 
pET9dCaM – wt CaM cloned in pET9D plasmid (p229) 
 
pnCaMChlor – nCaM cloned in pACMIP plasmid (p 
 
pcCaMKan – cCAM cloned in pET28a (p278) 
 
pCaMNNKan – CAMNN cloned in pET28a (p281) 
 
pCaMCCkan – CAMCC cloned in pET28a (p282) 
 
pCaM-1TNCKan – CAM-1TnC cloned in pET28a (p247) 
 
pCaM-2TNCKan – CAM-2TnC cloned in pET28a (p237) 
 
pCaM-3TNCKan – CAM-3TnC cloned in pET28a (p248) 
 
pCaM-4TNCKan – CAM-4TnC cloned in pET28a (p301) 
 
pHuCaMCtermCys – Cysteine-modified C-terminal CaM cloned in pRSETA plasmid (p529) 
) 












B. 1 – The OpenSPR™. 
Highlighting the OpenSPR™ machine, displaying the different parts of the apparatus. Displayed with 






SPR Raw Data  
Table C.1 - Binding Kinetics of CaM-TnC chimeric mutants with cNOS peptides 
CaM 
Protein 
nNOS Peptide eNOS Peptide 
Kon (10
4 M-1s-1) Koff (10
-4 s-1) KD (nM) Kon (10
4 M-1s-1) Koff (10
-4 s-1) KD (nM) 
wt CaM 9.77 ± 0.03 14 ± 0.003 14.4 ± 0.09 15.8 ± 0.02 18.9 ± 0.01 12.0 ± 0.17 
1TnC 5.02 ± 5.20 16.4 ± 3.80 15.6 ± 1.80 9.11 ± 0.93 10.0 ± 0.27 11.1 ± 0.78 
2TnC 14.8 ± 5.90 28.0 ± 9.10 19.3 ± 1.60 13.6 ± 1.90 4.13 ± 5.80 6.91 ± 1.90 
3TnC 16.2 ± 1.40 35.9 ± 19.00 21.8 ± 9.80 27.7 ± 0.21 31.4 ± 1.80 19.0 ± 6.20 
4TnC 26.0 ± 2.00 27.8 ± 1.50 10.7 ± 0.28 17.7 ± 3.90  69.6 ± 43.0  37.8 ± 16.0 
 
Table C.2 - Binding kinetics of CaM EF-hand pair mutants with cNOS peptides 
CaM 
Protein 
nNOS Peptide eNOS Peptide 
Kon (10
4 M-1s-1) Koff (10
-4 s-1) KD (nM) Kon (10
4 M-1s-1) Koff (10
-4 s-1) KD (nM) 
wt CaM 9.77 ± 0.03 14 ± 0.003 14.4 ± 0.09 15.8 ± 0.02 18.9 ± 0.001 12.0 ± 0.17 
nCaM (a) NAB (b) NAB NAB NAB NAB NAB 
cCaM (a) NAB NAB NAB NAB NAB NAB 
CaM NN 17.6 ± 2.20 18.3 ± 4.80 10.2 ± 1.5 30.5 ± 15.3  31.6 ± 0.04 10.4 ± 0.06  
CaM CC 5.05 ± 7.10 23.8 ± 17.0  14.9 ± 8.9 20.9 ± 2.00 12.5 ± 3.70 6.07 ± 2.40  
(a) These constructs were fit against a 1:2 binding model 
(b) No apparent binding 
 
Table C.3 - Binding Kinetics of CaM Phosphomimetic mutants with cNOS peptides 
CaM 
Protein 
nNOS Peptide eNOS Peptide 
Kon (10
4 M-1s-1) Koff (10
-4 s-1) KD (nM) Kon (10
4 M-1s-1) Koff (10
-4 s-1) KD (nM) 
wt CaM 9.77 ± 0.03 14 ± 0.003 14.4 ± 0.09 15.8 ± 0.02 18.9 ± 0.001 12.0 ± 0.17 
T79D 6.19 ± 0.58  16.2 ± 1.70 26.1 ± 0.57 10.7 ± 2.80 20.5 ± 3.10 19.7 ± 2.00 
S81D 10.5 ± 2.40 16.9 ± 3.40 16.2 ± 0.60 9.64 ± 2.60 23.9 ± 7.70 24.6 ± 2.50 
T79D/S81D 5.97 ± 3.20  13.1 ± 5.30 22.8 ± 3.30 6.74 ± 13.0 20.9 ± 0.14 31.1 ± 0.32 
S101D 8.79 ± 0.005 19.1 ± 0.01 21.7 ± 1.40 7.54 ± 5.60 21.4 ± 19.0 26.6 ± 4.90 
Y99E 11.9 ± 1.70 30.7 ± 1.30 26.1 ± 2.60 9.17 ± 7.10 13.5 ± 10.0 14.9 ± 0.28 
 
